| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH11 SETX MYO1D MYO5A MYO6 ABCA13 ABCA12 ACSL4 STARD9 SHPRH ATP11C ACSBG2 CHD6 DNA2 HSPA2 HSPA5 PMS2P1 KIF13B ATP8B3 ACSL6 ABCC1 SMARCAL1 KIF21A ABCC11 ATP10A ABCC6 ATP10D FBH1 ABCB10 MYO1F | 1.32e-09 | 614 | 270 | 30 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH11 MYO1D MYO5A MYO6 STARD9 MYO18B KIF13B KIF21A MYO1F MYO16 | 4.68e-06 | 118 | 270 | 10 | GO:0003774 |
| GeneOntologyMolecularFunction | actin binding | MYH11 MYO1D MYO5A MYO6 TWF1 SPTBN5 MYOZ1 AFDN MYO18B CNN3 HIP1R MIB2 PDLIM4 MYO1F PPP1R18 LSP1 SNCA TNS1 MYO16 MYBPC2 | 9.03e-06 | 479 | 270 | 20 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | DLG5 MYH11 MYO1D MYO5A GAPDH MYO6 CKAP5 TWF1 SPTBN5 MYOZ1 STARD9 KCNQ2 DLG1 AFDN MYO18B TRIM36 MAP4K4 HSPA2 CNN3 KIF13B KIF21A CAPN2 HIP1R MIB2 RMDN2 PDLIM4 MYO1F PPP1R18 LSP1 SNCA TNS1 MYO16 MYBPC2 | 1.50e-05 | 1099 | 270 | 33 | GO:0008092 |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.32e-05 | 28 | 270 | 5 | GO:0140326 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA13 ABCA12 ATP11C CHD6 DNA2 HSPA2 HSPA5 PMS2P1 KIF13B ATP8B3 ABCC1 KIF21A ABCC11 ATP10A ABCC6 ATP10D FBH1 ABCB10 | 3.44e-05 | 441 | 270 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.96e-05 | 49 | 270 | 6 | GO:0140359 | |
| GeneOntologyMolecularFunction | actin filament binding | MYH11 MYO1D MYO5A MYO6 TWF1 SPTBN5 AFDN MYO18B CNN3 HIP1R MYO1F MYO16 | 6.50e-05 | 227 | 270 | 12 | GO:0051015 |
| GeneOntologyMolecularFunction | glutathione binding | 8.62e-05 | 18 | 270 | 4 | GO:0043295 | |
| GeneOntologyMolecularFunction | calcium ion binding | CAPN9 MYO5A CDH23 MELK ITPR3 CAPN8 FAT1 FAT2 PLCB4 HSPA5 FAT4 STAB2 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGB1 PCDHGA6 FAT3 CAPN2 MYOF LRP1 UNC13C LTBP3 SNCA | 8.79e-05 | 749 | 270 | 24 | GO:0005509 |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 1.30e-04 | 8 | 270 | 3 | GO:0015431 | |
| GeneOntologyMolecularFunction | ligase activity | ACACA ACACB WARS2 ACSL4 CTPS2 ACSBG2 ACSL6 LARS2 PARS2 CTPS1 | 1.33e-04 | 174 | 270 | 10 | GO:0016874 |
| GeneOntologyMolecularFunction | oligopeptide binding | 1.34e-04 | 20 | 270 | 4 | GO:1900750 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.52e-04 | 38 | 270 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | 3-phosphoinositide-dependent protein kinase activity | 1.82e-04 | 2 | 270 | 2 | GO:0004676 | |
| GeneOntologyMolecularFunction | acetyl-CoA carboxylase activity | 1.82e-04 | 2 | 270 | 2 | GO:0003989 | |
| GeneOntologyMolecularFunction | CTP synthase activity | 1.82e-04 | 2 | 270 | 2 | GO:0003883 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 1.93e-04 | 9 | 270 | 3 | GO:0034040 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | SETX NT5C3A WARS2 CNOT6 POP1 SHPRH DKC1 DCLRE1A CHD6 DNA2 DNMT3B PMS2P1 EXO5 POLR1A SMARCAL1 QTRT2 LARS2 ERN2 PARS2 FBH1 MARF1 | 1.97e-04 | 645 | 270 | 21 | GO:0140640 |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 2.73e-04 | 10 | 270 | 3 | GO:0043225 | |
| GeneOntologyMolecularFunction | arachidonate-CoA ligase activity | 3.72e-04 | 11 | 270 | 3 | GO:0047676 | |
| GeneOntologyMolecularFunction | glycosylceramide flippase activity | 5.42e-04 | 3 | 270 | 2 | GO:0140351 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 6.16e-04 | 51 | 270 | 5 | GO:0140303 | |
| GeneOntologyMolecularFunction | phospholipase binding | 8.73e-04 | 32 | 270 | 4 | GO:0043274 | |
| GeneOntologyMolecularFunction | metal cluster binding | 9.14e-04 | 83 | 270 | 6 | GO:0051540 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | SETX SHPRH DKC1 DCLRE1A CHD6 DNA2 DNMT3B PMS2P1 EXO5 SMARCAL1 FBH1 | 9.22e-04 | 262 | 270 | 11 | GO:0140097 |
| GeneOntologyMolecularFunction | long-chain fatty acid-CoA ligase activity | 9.86e-04 | 15 | 270 | 3 | GO:0004467 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 9.86e-04 | 15 | 270 | 3 | GO:0008559 | |
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activity | 1.07e-03 | 4 | 270 | 2 | GO:0106292 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.10e-03 | 34 | 270 | 4 | GO:0042910 | |
| GeneOntologyMolecularFunction | floppase activity | 1.20e-03 | 16 | 270 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.44e-03 | 196 | 270 | 9 | GO:0005319 | |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 1.44e-03 | 17 | 270 | 3 | GO:0004198 | |
| GeneOntologyMolecularFunction | flippase activity | 1.44e-03 | 17 | 270 | 3 | GO:0140327 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.72e-03 | 127 | 270 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | dinitrosyl-iron complex binding | 1.77e-03 | 5 | 270 | 2 | GO:0035731 | |
| GeneOntologyMolecularFunction | DNA/RNA hybrid binding | 1.77e-03 | 5 | 270 | 2 | GO:0071667 | |
| GeneOntologyMolecularFunction | inositol 1,3,4,5 tetrakisphosphate binding | 1.77e-03 | 5 | 270 | 2 | GO:0043533 | |
| GeneOntologyMolecularFunction | magnesium ion binding | RPS6KA1 NT5C3A STK11 ATP11C ATP8B3 POLR1A ERN2 ATP10A ATP10D SNCA | 2.04e-03 | 247 | 270 | 10 | GO:0000287 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RHOJ ABCA13 ABCA12 DNAJC27 ATP11C CHD6 DNA2 HSPA2 HSPA5 PMS2P1 KIF13B ATP8B3 ABCC1 KIF21A ABCC11 ATP10A ABCC6 ATP10D FBH1 ABCB10 RAB7B | 2.05e-03 | 775 | 270 | 21 | GO:0017111 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | DCAF1 TNIK PDPK1 RPS6KA1 NT5C3A DGKQ CMAS MELK TWF1 NEK4 FCSK STK11 PIK3CB STRADA DKC1 DLG1 MAP4K4 PMS2P1 POLR1A PDPK2P ERN2 DGKI CDK1 FGGY | 2.14e-03 | 938 | 270 | 24 | GO:0016772 |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 2.35e-03 | 20 | 270 | 3 | GO:0046624 | |
| GeneOntologyMolecularFunction | translation elongation factor activity | 2.35e-03 | 20 | 270 | 3 | GO:0003746 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | NAT8L GALE GLS2 ACACA ACACB MYO5A GAPDH CYP8B1 ETFA AS3MT IREB2 UROC1 CMAS ACSL4 ADHFE1 CTPS2 ALDH1L2 CYP7B1 ACSBG2 MTCH2 ACSL6 COL6A1 ABCC1 PTGES SHMT1 PON3 NOX4 GSTA1 SCAP AASS NR5A2 MTR CYP2U1 SNCA CTPS1 UEVLD | 8.85e-08 | 1035 | 270 | 36 | GO:0019752 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | NAT8L GALE GLS2 ACACA ACACB MYO5A GAPDH CYP8B1 ETFA AS3MT IREB2 UROC1 CMAS ACSL4 ADHFE1 CTPS2 ALDH1L2 CYP7B1 ACSBG2 MTCH2 ACSL6 COL6A1 ABCC1 PTGES SHMT1 PON3 NOX4 GSTA1 SCAP AASS NR5A2 MTR CYP2U1 SNCA CTPS1 UEVLD | 1.52e-07 | 1058 | 270 | 36 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | NAT8L GALE GLS2 ACACA ACACB MYO5A GAPDH CYP8B1 ETFA AS3MT IREB2 UROC1 CMAS ACSL4 ADHFE1 CTPS2 ALDH1L2 CYP7B1 ACSBG2 MTCH2 ACSL6 COL6A1 ABCC1 PTGES SHMT1 PON3 NOX4 GSTA1 SCAP AASS NR5A2 MTR CYP2U1 SNCA CTPS1 UEVLD | 1.74e-07 | 1064 | 270 | 36 | GO:0006082 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CDH23 FAT1 FAT2 PTPRM PIK3CB PKD1 FAT4 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGB1 PCDHGA6 FAT3 | 1.18e-06 | 187 | 270 | 13 | GO:0007156 |
| GeneOntologyBiologicalProcess | positive regulation of translational termination | 8.79e-06 | 4 | 270 | 3 | GO:0045905 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | TNIK DLG5 SETX ABCA13 CKAP5 TSC2 TBC1D24 TWF1 CNOT6 RGMA STK11 BOK DKC1 DLG1 AFDN MAP4K4 HSPA5 ACSL6 CAPN2 HIP1R EIF5A2 NOX4 NCAPH ATP10A PDLIM4 EIF5AL1 LMAN1 PLXNC1 CD28 PEBP1 CAPRIN2 EIF5A LRP1 GRIP2 CDK1 CERS1 SNCA PLCE1 | 8.80e-06 | 1366 | 270 | 38 | GO:0051130 |
| GeneOntologyBiologicalProcess | positive regulation of translational elongation | 2.18e-05 | 5 | 270 | 3 | GO:0045901 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | NAT8L MYO5A MYO6 RPS6KA1 CKAP5 TSC2 TBC1D24 ITPR3 NALCN SORCS2 SLC17A7 KCNQ2 DLG1 AFDN PLCB4 SLC4A8 LAMA2 GRIA4 ZDHHC17 GRM3 PDLIM4 MYOF P2RX2 SORCS3 DGKI UNC13C GRIP2 SNCA | 3.87e-05 | 931 | 270 | 28 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | NAT8L MYO5A MYO6 RPS6KA1 CKAP5 TSC2 TBC1D24 ITPR3 NALCN SORCS2 SLC17A7 KCNQ2 DLG1 AFDN PLCB4 SLC4A8 LAMA2 GRIA4 ZDHHC17 GRM3 PDLIM4 MYOF P2RX2 SORCS3 DGKI UNC13C GRIP2 SNCA | 3.87e-05 | 931 | 270 | 28 | GO:0007268 |
| GeneOntologyBiologicalProcess | acyl-CoA biosynthetic process | 4.15e-05 | 49 | 270 | 6 | GO:0071616 | |
| GeneOntologyBiologicalProcess | thioester biosynthetic process | 4.15e-05 | 49 | 270 | 6 | GO:0035384 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | NAT8L MYO5A MYO6 RPS6KA1 CKAP5 TSC2 TBC1D24 ITPR3 NALCN SORCS2 SLC17A7 KCNQ2 DLG1 AFDN PLCB4 SLC4A8 LAMA2 GRIA4 ZDHHC17 GRM3 PDLIM4 MYOF P2RX2 SORCS3 DGKI UNC13C GRIP2 SNCA | 4.50e-05 | 939 | 270 | 28 | GO:0099537 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | MYO5A MYO6 CKAP5 TBC1D24 ITPR3 NALCN SORCS2 KCNQ2 AFDN PLCB4 SLC4A8 LAMA2 GRIA4 ZDHHC17 GRM3 MYOF P2RX2 SORCS3 DGKI UNC13C GRIP2 SNCA | 6.65e-05 | 663 | 270 | 22 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | MYO5A MYO6 CKAP5 TBC1D24 ITPR3 NALCN SORCS2 KCNQ2 AFDN PLCB4 SLC4A8 LAMA2 GRIA4 ZDHHC17 GRM3 MYOF P2RX2 SORCS3 DGKI UNC13C GRIP2 SNCA | 6.80e-05 | 664 | 270 | 22 | GO:0099177 |
| GeneOntologyBiologicalProcess | leukotriene transport | 7.47e-05 | 7 | 270 | 3 | GO:0071716 | |
| GeneOntologyBiologicalProcess | synaptic signaling | NAT8L MYO5A MYO6 RPS6KA1 CKAP5 TSC2 TBC1D24 ITPR3 NALCN SORCS2 SLC17A7 KCNQ2 DLG1 AFDN PLCB4 SLC4A8 LAMA2 GRIA4 ZDHHC17 GRM3 PDLIM4 MYOF P2RX2 SORCS3 DGKI UNC13C GRIP2 SNCA | 8.75e-05 | 976 | 270 | 28 | GO:0099536 |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | NAT8L GALE ACACA ACACB MYO5A GAPDH CYP8B1 ETFA UROC1 ACSL4 ALDH1L2 CYP7B1 ACSBG2 MTCH2 ACSL6 COL6A1 PTGES PON3 GSTA1 SCAP NR5A2 CYP2U1 SNCA | 1.01e-04 | 731 | 270 | 23 | GO:0032787 |
| GeneOntologyBiologicalProcess | amino acid metabolic process | NAT8L GLS2 ETFA UROC1 WARS2 ADHFE1 CTPS2 SHMT1 NOX4 LARS2 PARS2 AASS MTR CTPS1 | 1.32e-04 | 332 | 270 | 14 | GO:0006520 |
| GeneOntologyBiologicalProcess | lipid translocation | 1.32e-04 | 60 | 270 | 6 | GO:0034204 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 1.41e-04 | 147 | 270 | 9 | GO:0099565 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate biosynthetic process | 1.45e-04 | 61 | 270 | 6 | GO:0033866 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate biosynthetic process | 1.45e-04 | 61 | 270 | 6 | GO:0034030 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate biosynthetic process | 1.45e-04 | 61 | 270 | 6 | GO:0034033 | |
| GeneOntologyBiologicalProcess | amide metabolic process | ACACA ACACB ABCA12 UROC1 CMAS ACSL4 ALDH1L2 ACSBG2 ACSL6 ENPP7 SHMT1 CPE GSR GSTA1 GSTA2 AASS CERS1 SNCA | 1.49e-04 | 511 | 270 | 18 | GO:0043603 |
| GeneOntologyBiologicalProcess | malonyl-CoA biosynthetic process | 1.71e-04 | 2 | 270 | 2 | GO:2001295 | |
| GeneOntologyBiologicalProcess | 'de novo' CTP biosynthetic process | 1.71e-04 | 2 | 270 | 2 | GO:0044210 | |
| GeneOntologyBiologicalProcess | regulation of translational termination | 1.76e-04 | 9 | 270 | 3 | GO:0006449 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | SETX CKAP5 TSC2 TWF1 SPTBN5 BOK MAP4K4 HSPA2 COL6A1 EIF5A2 ERN2 EIF5AL1 ATG3 PLXNC1 SUPT16H EIF5A LRP1 CDK1 CERS1 CTSV | 1.95e-04 | 617 | 270 | 20 | GO:0022411 |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 2.06e-04 | 65 | 270 | 6 | GO:0097035 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | ACACA ACACB MYO5A ABCA12 PDPK1 CDH23 IREB2 LYST ITPR3 STK11 BOK PIK3CB SLC17A7 CYP7B1 PLCB4 MAP4K4 MTCH2 SPPL2C ENPP7 SLC4A8 WFS1 NOX4 APOB ABCC6 RHD CEMIP P2RX2 NR5A2 LRP1 SNCA EPB42 PLCE1 | 2.19e-04 | 1249 | 270 | 32 | GO:0048878 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CDH23 FAT1 FAT2 PTPRM PIK3CB PKD1 FAT4 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGB1 PCDHGA6 FAT3 | 2.64e-04 | 313 | 270 | 13 | GO:0098742 |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 3.19e-04 | 130 | 270 | 8 | GO:0060079 | |
| GeneOntologyCellularComponent | somatodendritic compartment | MYO1D MYO5A MYO6 PDPK1 CKAP5 MPDZ IREB2 TSC2 PALMD ITPR3 ACSL4 SORCS2 KCNAB1 DLG1 AFDN OSBP2 PLCB4 HSPA5 CNN3 SLC4A8 WFS1 FAT3 KIF21A CAPN2 HIP1R LAMA2 GRIA4 APOB CPE PDPK2P GRM3 PDLIM4 EIF5AL1 P2RX2 PEBP1 EIF5A LRP1 DGKI GRIP2 SNCA CTSV | 2.17e-08 | 1228 | 270 | 41 | GO:0036477 |
| GeneOntologyCellularComponent | dendrite | MYO1D MYO5A CKAP5 MPDZ TSC2 PALMD ITPR3 SORCS2 KCNAB1 DLG1 OSBP2 PLCB4 HSPA5 CNN3 SLC4A8 WFS1 FAT3 KIF21A CAPN2 HIP1R LAMA2 GRIA4 CPE GRM3 PDLIM4 EIF5AL1 P2RX2 EIF5A LRP1 DGKI GRIP2 | 2.51e-07 | 858 | 270 | 31 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | MYO1D MYO5A CKAP5 MPDZ TSC2 PALMD ITPR3 SORCS2 KCNAB1 DLG1 OSBP2 PLCB4 HSPA5 CNN3 SLC4A8 WFS1 FAT3 KIF21A CAPN2 HIP1R LAMA2 GRIA4 CPE GRM3 PDLIM4 EIF5AL1 P2RX2 EIF5A LRP1 DGKI GRIP2 | 2.65e-07 | 860 | 270 | 31 | GO:0097447 |
| GeneOntologyCellularComponent | neuronal cell body | MYO1D MYO5A MYO6 PDPK1 CKAP5 IREB2 TSC2 ITPR3 ACSL4 SORCS2 KCNAB1 DLG1 HSPA5 CNN3 SLC4A8 CAPN2 HIP1R GRIA4 APOB CPE PDPK2P EIF5AL1 P2RX2 PEBP1 EIF5A LRP1 DGKI GRIP2 SNCA CTSV | 4.49e-07 | 835 | 270 | 30 | GO:0043025 |
| GeneOntologyCellularComponent | vesicle membrane | MYO6 ABCA13 ABCA12 DGKQ SLC18B1 TBC1D24 ITPR3 KIAA0319 BOK PTPRB PKD1 SORCS2 SLC17A7 DLG1 ATP11C MARCHF11 SPPL2C ATP8B3 DNAJC13 STAB2 SLC4A8 WFS1 HIP1R ABCC11 GRIA4 APOB CPE ZDHHC17 PDLIM4 CEMIP MYOF SCAP LMAN1 SLC26A7 LRP1 DGKI RAB7B UNC13C SNCA UEVLD | 4.70e-07 | 1325 | 270 | 40 | GO:0012506 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | MYO6 ABCA13 ABCA12 SLC18B1 TBC1D24 ITPR3 KIAA0319 BOK PTPRB PKD1 SORCS2 SLC17A7 DLG1 ATP11C MARCHF11 SPPL2C ATP8B3 DNAJC13 STAB2 SLC4A8 WFS1 HIP1R ABCC11 GRIA4 APOB CPE ZDHHC17 PDLIM4 CEMIP MYOF SCAP LMAN1 SLC26A7 LRP1 DGKI RAB7B UNC13C SNCA UEVLD | 8.90e-07 | 1307 | 270 | 39 | GO:0030659 |
| GeneOntologyCellularComponent | asymmetric synapse | TNIK DLG5 GAPDH MYO6 PDPK1 MPDZ TSC2 SORCS2 DLG1 AFDN PLCB4 SLC4A8 HIP1R GRIA4 PDPK2P GRM3 PLXNC1 LRP1 SORCS3 DGKI GRIP2 | 1.15e-06 | 477 | 270 | 21 | GO:0032279 |
| GeneOntologyCellularComponent | cell body | MYO1D MYO5A MYO6 PDPK1 CKAP5 IREB2 TSC2 ITPR3 ACSL4 PTPN13 SORCS2 KCNAB1 DLG1 HSPA5 CNN3 SLC4A8 CAPN2 HIP1R GRIA4 APOB CPE PDPK2P EIF5AL1 P2RX2 PEBP1 EIF5A LRP1 DGKI GRIP2 SNCA CTSV | 1.37e-06 | 929 | 270 | 31 | GO:0044297 |
| GeneOntologyCellularComponent | apical part of cell | TNIK MYO6 CDH23 MPDZ ITPR3 SPTBN5 FAT1 DLG1 AFDN PAPPA2 ABCC1 FAT4 SLC4A8 HIP1R ABCC11 NOX4 ABCC6 SLC47A2 SLC26A7 P2RX2 PEBP1 LRP1 CTSV | 2.96e-06 | 592 | 270 | 23 | GO:0045177 |
| GeneOntologyCellularComponent | neuron to neuron synapse | TNIK DLG5 GAPDH MYO6 PDPK1 MPDZ TSC2 SORCS2 DLG1 AFDN PLCB4 SLC4A8 HIP1R GRIA4 PDPK2P GRM3 PLXNC1 LRP1 SORCS3 DGKI GRIP2 | 4.88e-06 | 523 | 270 | 21 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density | TNIK DLG5 GAPDH MYO6 PDPK1 MPDZ TSC2 SORCS2 DLG1 AFDN PLCB4 HIP1R GRIA4 PDPK2P GRM3 LRP1 SORCS3 DGKI GRIP2 | 7.10e-06 | 451 | 270 | 19 | GO:0014069 |
| GeneOntologyCellularComponent | unconventional myosin complex | 8.36e-06 | 11 | 270 | 4 | GO:0016461 | |
| GeneOntologyCellularComponent | postsynapse | TNIK DLG5 MYO5A GAPDH MYO6 PDPK1 KCTD8 MPDZ DGKQ TSC2 PALMD SORCS2 DLG1 AFDN PLCB4 CNN3 CAPN2 HIP1R LAMA2 GRIA4 NBEA PDPK2P ZDHHC17 GRM3 PDLIM4 P2RX2 LRP1 SORCS3 DGKI GRIP2 SNCA | 8.78e-06 | 1018 | 270 | 31 | GO:0098794 |
| GeneOntologyCellularComponent | myosin complex | 1.07e-05 | 59 | 270 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 2.46e-05 | 14 | 270 | 4 | GO:1990531 | |
| GeneOntologyCellularComponent | postsynaptic specialization | TNIK DLG5 GAPDH MYO6 PDPK1 MPDZ TSC2 SORCS2 DLG1 AFDN PLCB4 HIP1R GRIA4 PDPK2P GRM3 LRP1 SORCS3 DGKI GRIP2 | 3.23e-05 | 503 | 270 | 19 | GO:0099572 |
| GeneOntologyCellularComponent | transport vesicle membrane | ABCA12 SLC18B1 SLC17A7 DLG1 SLC4A8 WFS1 CPE MYOF SCAP LMAN1 DGKI UNC13C SNCA | 1.21e-04 | 293 | 270 | 13 | GO:0030658 |
| GeneOntologyCellularComponent | glutamatergic synapse | TNIK DLG5 MYO5A GAPDH MYO6 MPDZ DGKQ TSC2 NEDD8 DLG1 PLCB4 CNN3 SLC4A8 HIP1R GRIA4 NBEA ZDHHC17 GRM3 P2RX2 PLXNC1 LRP1 SORCS3 DGKI GRIP2 | 1.65e-04 | 817 | 270 | 24 | GO:0098978 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | NAT8L CYP8B1 ITPR3 ACSL4 BOK PIGA DLG1 CYP7B1 ATP11C HSPA5 ALG12 SPPL2C ATP8B3 ACSL6 LMF1 WFS1 PTGES PON3 EIF5A2 NOX4 APOB ERN2 ATP10A ABCC6 ATP10D EIF5AL1 SCAP LMAN1 EIF5A CYP2U1 CDK1 CERS1 SNCA | 2.35e-04 | 1327 | 270 | 33 | GO:0042175 |
| GeneOntologyCellularComponent | myosin filament | 2.78e-04 | 25 | 270 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 3.08e-04 | 46 | 270 | 5 | GO:0005790 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | NAT8L CYP8B1 ITPR3 ACSL4 BOK PIGA DLG1 CYP7B1 ATP11C HSPA5 ALG12 SPPL2C ATP8B3 ACSL6 LMF1 WFS1 PTGES PON3 EIF5A2 NOX4 APOB ERN2 ATP10A ABCC6 ATP10D EIF5AL1 SCAP LMAN1 EIF5A CYP2U1 CDK1 CERS1 | 3.20e-04 | 1293 | 270 | 32 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | NAT8L CYP8B1 ITPR3 ACSL4 BOK PIGA DLG1 CYP7B1 ATP11C HSPA5 ALG12 SPPL2C ATP8B3 ACSL6 LMF1 WFS1 PTGES PON3 EIF5A2 NOX4 APOB ERN2 ATP10A ABCC6 ATP10D EIF5AL1 SCAP LMAN1 EIF5A CYP2U1 CDK1 CERS1 | 3.47e-04 | 1299 | 270 | 32 | GO:0098827 |
| GeneOntologyCellularComponent | neuron spine | PALMD SORCS2 CNN3 HIP1R LAMA2 GRIA4 GRM3 PDLIM4 P2RX2 DGKI GRIP2 | 3.89e-04 | 247 | 270 | 11 | GO:0044309 |
| GeneOntologyCellularComponent | cytoophidium | 4.94e-04 | 3 | 270 | 2 | GO:0097268 | |
| GeneOntologyCellularComponent | presynaptic active zone | 5.04e-04 | 141 | 270 | 8 | GO:0048786 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH11 ACACA MYO1D MYO5A MYO6 TWF1 SPTBN5 MYOZ1 MYO18B CNN3 CAPN2 HIP1R NOX4 PDLIM4 MYO1F LSP1 SNCA MYO16 | 5.34e-04 | 576 | 270 | 18 | GO:0015629 |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 5.51e-04 | 179 | 270 | 9 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 5.51e-04 | 179 | 270 | 9 | GO:0030672 | |
| GeneOntologyCellularComponent | axon | SETX MYO1D MYO5A MYO6 IREB2 TSC2 TBC1D24 SLC17A7 KCNQ2 KCNAB1 DLG1 AFDN KIF13B SLC4A8 PCDHGB1 KIF21A GRIA4 GRM3 P2RX2 PEBP1 LRP1 DGKI UNC13C SNCA | 5.78e-04 | 891 | 270 | 24 | GO:0030424 |
| GeneOntologyCellularComponent | synaptic membrane | KCTD8 SORCS2 DLG1 AFDN SLC4A8 HIP1R GRIA4 NBEA CPE ZDHHC17 GRM3 PDLIM4 P2RX2 LRP1 SORCS3 DGKI UNC13C GRIP2 | 6.14e-04 | 583 | 270 | 18 | GO:0097060 |
| GeneOntologyCellularComponent | exocytic vesicle | MYO5A SLC18B1 SLC17A7 DLG1 SLC4A8 WFS1 MYOF SYTL5 PEBP1 DGKI UNC13C SNCA | 9.85e-04 | 320 | 270 | 12 | GO:0070382 |
| GeneOntologyCellularComponent | actin-based cell projection | MYO1D MYO5A MYO6 CDH23 TWF1 FAT1 DLG1 KIF13B ENPP7 MYO1F CTSV | 1.03e-03 | 278 | 270 | 11 | GO:0098858 |
| GeneOntologyCellularComponent | organelle outer membrane | ACACB ITPR3 ACSL4 BOK TOMM40L MTCH2 ACSL6 QTRT2 PEBP1 FAM210B SNCA | 1.06e-03 | 279 | 270 | 11 | GO:0031968 |
| GeneOntologyCellularComponent | microvillus | 1.10e-03 | 123 | 270 | 7 | GO:0005902 | |
| GeneOntologyCellularComponent | outer membrane | ACACB ITPR3 ACSL4 BOK TOMM40L MTCH2 ACSL6 QTRT2 PEBP1 FAM210B SNCA | 1.13e-03 | 281 | 270 | 11 | GO:0019867 |
| GeneOntologyCellularComponent | mitochondrial outer membrane | ACACB ACSL4 BOK TOMM40L MTCH2 ACSL6 QTRT2 PEBP1 FAM210B SNCA | 1.22e-03 | 241 | 270 | 10 | GO:0005741 |
| GeneOntologyCellularComponent | transport vesicle | MYO5A ABCA12 SLC18B1 SLC17A7 DLG1 SLC4A8 WFS1 CPE MYOF SCAP LMAN1 SYTL5 PEBP1 DGKI UNC13C SNCA | 1.24e-03 | 519 | 270 | 16 | GO:0030133 |
| GeneOntologyCellularComponent | dendritic spine | 1.25e-03 | 242 | 270 | 10 | GO:0043197 | |
| GeneOntologyCellularComponent | mitochondrial matrix | NAT8L GLS2 ACACB MRPS12 ETFA WARS2 ADHFE1 ALDH1L2 DNA2 LARS2 PARS2 GSR AASS MRPS9 CDK1 SNCA | 1.34e-03 | 523 | 270 | 16 | GO:0005759 |
| GeneOntologyCellularComponent | filamentous actin | 1.42e-03 | 38 | 270 | 4 | GO:0031941 | |
| GeneOntologyCellularComponent | terminal bouton | 1.54e-03 | 96 | 270 | 6 | GO:0043195 | |
| GeneOntologyCellularComponent | apical plasma membrane | TNIK MPDZ ITPR3 FAT1 DLG1 PAPPA2 ABCC1 SLC4A8 HIP1R ABCC11 NOX4 ABCC6 SLC47A2 SLC26A7 P2RX2 | 1.76e-03 | 487 | 270 | 15 | GO:0016324 |
| GeneOntologyCellularComponent | synaptic vesicle | MYO5A SLC18B1 SLC17A7 DLG1 SLC4A8 WFS1 MYOF PEBP1 DGKI UNC13C SNCA | 1.89e-03 | 300 | 270 | 11 | GO:0008021 |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 2.41e-03 | 6 | 270 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | excitatory synapse | 2.67e-03 | 107 | 270 | 6 | GO:0060076 | |
| GeneOntologyCellularComponent | presynapse | TNIK MYO5A MYO6 KCTD8 DGKQ SLC18B1 TBC1D24 ITPR3 SLC17A7 DLG1 AFDN SLC4A8 WFS1 GRIA4 ZDHHC17 GRM3 MYOF P2RX2 PEBP1 DGKI UNC13C SNCA | 2.70e-03 | 886 | 270 | 22 | GO:0098793 |
| GeneOntologyCellularComponent | presynaptic membrane | 3.35e-03 | 277 | 270 | 10 | GO:0042734 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 3.40e-03 | 78 | 270 | 5 | GO:0048787 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 3.65e-03 | 49 | 270 | 4 | GO:0099092 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 4.38e-03 | 157 | 270 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | distal axon | SETX MYO5A TSC2 TBC1D24 SLC4A8 PCDHGB1 GRIA4 P2RX2 PEBP1 LRP1 DGKI UNC13C SNCA | 4.51e-03 | 435 | 270 | 13 | GO:0150034 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH11 TWF1 STK11 MYOZ1 MYO18B COL6A1 PDLIM4 LMAN1 MYOM2 MYBPC2 | 4.63e-03 | 290 | 270 | 10 | GO:0043292 |
| Domain | P-loop_NTPase | DLG5 MYH11 SETX THNSL1 MYO1D MYO5A RHOJ MYO6 ABCA13 ABCA12 DNAJC27 NDST3 CTPS2 STARD9 SHPRH DLG1 CHD6 MYO18B DNA2 KIF13B ABCC1 SMARCAL1 KIF21A ABCC11 ABCC6 SBNO2 FBH1 ABCB10 MYO1F RAB7B CTPS1 MYO16 | 5.53e-07 | 848 | 267 | 32 | IPR027417 |
| Domain | MYOSIN_MOTOR | 9.75e-07 | 38 | 267 | 7 | PS51456 | |
| Domain | Myosin_head_motor_dom | 9.75e-07 | 38 | 267 | 7 | IPR001609 | |
| Domain | Myosin_head | 9.75e-07 | 38 | 267 | 7 | PF00063 | |
| Domain | MYSc | 9.75e-07 | 38 | 267 | 7 | SM00242 | |
| Domain | Cadherin | CDH23 KIAA0319 FAT1 FAT2 FAT4 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGB1 PCDHGA6 FAT3 | 1.03e-06 | 118 | 267 | 11 | IPR002126 |
| Domain | IF5A_HYPUSINE | 2.89e-06 | 3 | 267 | 3 | PS00302 | |
| Domain | Transl_elong_IF5A_C | 2.89e-06 | 3 | 267 | 3 | IPR020189 | |
| Domain | Transl_elong_IF5A | 2.89e-06 | 3 | 267 | 3 | IPR001884 | |
| Domain | eIF-5a | 2.89e-06 | 3 | 267 | 3 | SM01376 | |
| Domain | eIF-5a | 2.89e-06 | 3 | 267 | 3 | PF01287 | |
| Domain | Trans_elong_IF5A_hypusine_site | 2.89e-06 | 3 | 267 | 3 | IPR019769 | |
| Domain | Cadherin_CS | CDH23 FAT1 FAT2 FAT4 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGB1 PCDHGA6 FAT3 | 3.71e-06 | 109 | 267 | 10 | IPR020894 |
| Domain | CADHERIN_1 | CDH23 FAT1 FAT2 FAT4 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGB1 PCDHGA6 FAT3 | 5.13e-06 | 113 | 267 | 10 | PS00232 |
| Domain | Cadherin | CDH23 FAT1 FAT2 FAT4 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGB1 PCDHGA6 FAT3 | 5.13e-06 | 113 | 267 | 10 | PF00028 |
| Domain | - | CDH23 FAT1 FAT2 FAT4 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGB1 PCDHGA6 FAT3 | 5.56e-06 | 114 | 267 | 10 | 2.60.40.60 |
| Domain | CADHERIN_2 | CDH23 FAT1 FAT2 FAT4 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGB1 PCDHGA6 FAT3 | 5.56e-06 | 114 | 267 | 10 | PS50268 |
| Domain | CA | CDH23 FAT1 FAT2 FAT4 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGB1 PCDHGA6 FAT3 | 6.01e-06 | 115 | 267 | 10 | SM00112 |
| Domain | Cadherin-like | CDH23 FAT1 FAT2 FAT4 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGB1 PCDHGA6 FAT3 | 6.50e-06 | 116 | 267 | 10 | IPR015919 |
| Domain | - | 8.77e-06 | 95 | 267 | 9 | 2.60.120.200 | |
| Domain | PKD | 1.25e-05 | 11 | 267 | 4 | PS50093 | |
| Domain | PKD_dom | 1.25e-05 | 11 | 267 | 4 | IPR000601 | |
| Domain | - | 1.25e-05 | 11 | 267 | 4 | 2.60.40.670 | |
| Domain | P_typ_ATPase_c | 3.65e-05 | 14 | 267 | 4 | IPR032630 | |
| Domain | P-type_ATPase_N | 3.65e-05 | 14 | 267 | 4 | IPR032631 | |
| Domain | PhoLip_ATPase_C | 3.65e-05 | 14 | 267 | 4 | PF16212 | |
| Domain | PhoLip_ATPase_N | 3.65e-05 | 14 | 267 | 4 | PF16209 | |
| Domain | P-type_ATPase_IV | 3.65e-05 | 14 | 267 | 4 | IPR006539 | |
| Domain | ABC_TRANSPORTER_2 | 5.98e-05 | 48 | 267 | 6 | PS50893 | |
| Domain | ABC_tran | 5.98e-05 | 48 | 267 | 6 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 6.74e-05 | 49 | 267 | 6 | PS00211 | |
| Domain | ABC_transporter-like | 7.57e-05 | 50 | 267 | 6 | IPR003439 | |
| Domain | ConA-like_dom | FAT1 FAT2 PTPRM TRIM36 PAPPA2 FAT4 ZAN FAT3 LAMA2 NBEA LGALS8 LMAN1 | 7.77e-05 | 219 | 267 | 12 | IPR013320 |
| Domain | - | DCAF1 CFAP251 IFT172 BIRC6 LYST WDR3 KIF21A VPS8 NBEA WDR37 ZNF106 SCAP PLXNC1 IFT122 DCAF11 | 9.57e-05 | 333 | 267 | 15 | 2.130.10.10 |
| Domain | PKD | 9.69e-05 | 7 | 267 | 3 | PF00801 | |
| Domain | WD40/YVTN_repeat-like_dom | DCAF1 CFAP251 IFT172 BIRC6 LYST WDR3 KIF21A VPS8 NBEA WDR37 ZNF106 SCAP PLXNC1 IFT122 DCAF11 | 1.02e-04 | 335 | 267 | 15 | IPR015943 |
| Domain | IQ | 1.59e-04 | 81 | 267 | 7 | SM00015 | |
| Domain | Cadherin_tail | 1.72e-04 | 37 | 267 | 5 | PF15974 | |
| Domain | Cadherin_CBD | 1.72e-04 | 37 | 267 | 5 | IPR031904 | |
| Domain | WD_REPEATS_1 | DCAF1 CFAP251 IFT172 LYST WDR3 KIF21A VPS8 NBEA WDR37 ZNF106 SCAP IFT122 DCAF11 | 1.94e-04 | 278 | 267 | 13 | PS00678 |
| Domain | LAM_G_DOMAIN | 1.96e-04 | 38 | 267 | 5 | PS50025 | |
| Domain | WD_REPEATS_2 | DCAF1 CFAP251 IFT172 LYST WDR3 KIF21A VPS8 NBEA WDR37 ZNF106 SCAP IFT122 DCAF11 | 2.00e-04 | 279 | 267 | 13 | PS50082 |
| Domain | WD_REPEATS_REGION | DCAF1 CFAP251 IFT172 LYST WDR3 KIF21A VPS8 NBEA WDR37 ZNF106 SCAP IFT122 DCAF11 | 2.00e-04 | 279 | 267 | 13 | PS50294 |
| Domain | CTP_synthase_N | 2.04e-04 | 2 | 267 | 2 | IPR017456 | |
| Domain | GATase1_CTP_Synthase | 2.04e-04 | 2 | 267 | 2 | IPR033828 | |
| Domain | CTP_synthase | 2.04e-04 | 2 | 267 | 2 | IPR004468 | |
| Domain | CTP_synth_N | 2.04e-04 | 2 | 267 | 2 | PF06418 | |
| Domain | ACC_central | 2.04e-04 | 2 | 267 | 2 | PF08326 | |
| Domain | AcCoA_COase_cen | 2.04e-04 | 2 | 267 | 2 | IPR013537 | |
| Domain | PKD | 2.28e-04 | 9 | 267 | 3 | SM00089 | |
| Domain | PKD/Chitinase_dom | 2.28e-04 | 9 | 267 | 3 | IPR022409 | |
| Domain | Laminin_G_2 | 2.51e-04 | 40 | 267 | 5 | PF02210 | |
| Domain | - | 3.02e-04 | 64 | 267 | 6 | 3.40.50.1000 | |
| Domain | IQ_motif_EF-hand-BS | 3.07e-04 | 90 | 267 | 7 | IPR000048 | |
| Domain | ABC_transporter_CS | 3.17e-04 | 42 | 267 | 5 | IPR017871 | |
| Domain | Cadherin_C | 3.17e-04 | 42 | 267 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 3.17e-04 | 42 | 267 | 5 | PF16492 | |
| Domain | Hydrolase_3 | 3.22e-04 | 10 | 267 | 3 | PF08282 | |
| Domain | ABC_membrane | 3.46e-04 | 24 | 267 | 4 | PF00664 | |
| Domain | WD40_repeat_dom | DCAF1 CFAP251 IFT172 LYST WDR3 KIF21A VPS8 NBEA WDR37 ZNF106 SCAP IFT122 DCAF11 | 3.66e-04 | 297 | 267 | 13 | IPR017986 |
| Domain | IQ | 3.75e-04 | 93 | 267 | 7 | PS50096 | |
| Domain | LamG | 3.96e-04 | 44 | 267 | 5 | SM00282 | |
| Domain | - | DLG5 SETX THNSL1 RHOJ ABCA13 ABCA12 DNAJC27 NDST3 CTPS2 SHPRH DLG1 CHD6 DNA2 ABCC1 SMARCAL1 ABCC11 ABCC6 SBNO2 FBH1 ABCB10 MYO1F RAB7B CTPS1 | 4.69e-04 | 746 | 267 | 23 | 3.40.50.300 |
| Domain | THIOL_PROTEASE_CYS | 4.76e-04 | 26 | 267 | 4 | PS00139 | |
| Domain | IQ | 5.31e-04 | 71 | 267 | 6 | PF00612 | |
| Domain | THIOL_PROTEASE_ASN | 5.53e-04 | 27 | 267 | 4 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 5.53e-04 | 27 | 267 | 4 | PS00639 | |
| Domain | WD40_repeat | CFAP251 IFT172 LYST WDR3 KIF21A VPS8 NBEA WDR37 ZNF106 SCAP IFT122 DCAF11 | 5.72e-04 | 272 | 267 | 12 | IPR001680 |
| Domain | C2_III | 5.78e-04 | 12 | 267 | 3 | IPR033883 | |
| Domain | Calpain_III | 5.78e-04 | 12 | 267 | 3 | IPR022683 | |
| Domain | calpain_III | 5.78e-04 | 12 | 267 | 3 | SM00720 | |
| Domain | Pept_cys_AS | 6.38e-04 | 28 | 267 | 4 | IPR000169 | |
| Domain | ABC_TM1F | 6.38e-04 | 28 | 267 | 4 | PS50929 | |
| Domain | ABC1_TM_dom | 6.38e-04 | 28 | 267 | 4 | IPR011527 | |
| Domain | Calpain_III | 7.43e-04 | 13 | 267 | 3 | PF01067 | |
| Domain | Calpain_domain_III | 7.43e-04 | 13 | 267 | 3 | IPR022682 | |
| Domain | Calpain_cysteine_protease | 9.36e-04 | 14 | 267 | 3 | IPR022684 | |
| Domain | HAD-like_dom | 9.37e-04 | 79 | 267 | 6 | IPR023214 | |
| Domain | RA | 9.48e-04 | 31 | 267 | 4 | SM00314 | |
| Domain | - | 1.07e-03 | 32 | 267 | 4 | 3.40.1110.10 | |
| Domain | - | 1.07e-03 | 32 | 267 | 4 | 2.70.150.10 | |
| Domain | Peptidase_C2 | 1.16e-03 | 15 | 267 | 3 | PF00648 | |
| Domain | Peptidase_C2_calpain_cat | 1.16e-03 | 15 | 267 | 3 | IPR001300 | |
| Domain | CysPc | 1.16e-03 | 15 | 267 | 3 | SM00230 | |
| Domain | CALPAIN_CAT | 1.16e-03 | 15 | 267 | 3 | PS50203 | |
| Domain | Carboxyl_trans | 1.20e-03 | 4 | 267 | 2 | PF01039 | |
| Domain | COA_CT_CTER | 1.20e-03 | 4 | 267 | 2 | PS50989 | |
| Domain | COA_CT_NTER | 1.20e-03 | 4 | 267 | 2 | PS50980 | |
| Domain | Multidrug-R_assoc | 1.20e-03 | 4 | 267 | 2 | IPR005292 | |
| Domain | Carboxyl_trans | 1.20e-03 | 4 | 267 | 2 | IPR000022 | |
| Domain | Cyt_b245_heavy_chain | 1.20e-03 | 4 | 267 | 2 | IPR000778 | |
| Domain | COA_CT_N | 1.20e-03 | 4 | 267 | 2 | IPR011762 | |
| Domain | COA_CT_C | 1.20e-03 | 4 | 267 | 2 | IPR011763 | |
| Domain | WD40 | CFAP251 IFT172 LYST WDR3 KIF21A NBEA WDR37 ZNF106 SCAP IFT122 DCAF11 | 1.31e-03 | 259 | 267 | 11 | PF00400 |
| Domain | Laminin_G | 1.42e-03 | 58 | 267 | 5 | IPR001791 | |
| Domain | ATPase_P-typ_cyto_domN | 1.51e-03 | 35 | 267 | 4 | IPR023299 | |
| Domain | PTPc_motif | 1.53e-03 | 59 | 267 | 5 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.53e-03 | 59 | 267 | 5 | IPR003595 | |
| Domain | ATPase_P-typ_P_site | 1.68e-03 | 36 | 267 | 4 | IPR018303 | |
| Domain | PTPc | 1.68e-03 | 36 | 267 | 4 | SM00194 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | DLG5 GLS2 ACACA TSC2 STK11 PIK3CB ALDH1L2 DLG1 SHMT1 NOX4 NOX3 GRIA4 GRM3 ATG3 MTR CNTN3 GRIP2 | 1.80e-05 | 367 | 199 | 17 | M48346 |
| Pathway | REACTOME_HYPUSINE_SYNTHESIS_FROM_EIF5A_LYSINE | 2.71e-05 | 5 | 199 | 3 | MM14823 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 3.31e-05 | 44 | 199 | 6 | M11911 | |
| Pathway | KEGG_MTOR_SIGNALING_PATHWAY | 8.70e-05 | 52 | 199 | 6 | M7561 | |
| Pubmed | MYH11 GLS2 ACACB MYO1D MYO5A CWC27 LYST NEDD8 ACSL4 STK11 STARD9 DKC1 DLG1 ATP11C CHD6 HSPA2 HSPA5 DNMT3B KIF13B ADAP1 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGB1 PCDHGA6 KIF21A GRIA4 APOB ZDHHC17 NCAPH GSR CAPRIN2 SUPT16H MARF1 MRPS9 IFT122 MYOM2 SPAG17 MYBPC2 | 1.60e-11 | 1442 | 272 | 39 | 35575683 | |
| Pubmed | MYO5A GAPDH MYO6 CKAP5 CMAS BIRC6 F5 MELK ITPR3 CNOT6 ACSL4 PIGA HSPA2 MTCH2 HSPA5 ALG12 ABCC1 DNAJC13 CNOT10 CPD NCAPH LGALS8 LMAN1 PLXNC1 EIF5A MARF1 ANKRD17 LSP1 IFT122 CDK1 EIF3H CTPS1 | 9.18e-10 | 1168 | 272 | 32 | 19946888 | |
| Pubmed | TNIK ACACA ACACB MYO5A GAPDH ETFA CKAP5 PALMD CMAS BIRC6 TBC1D24 KCNQ2 KCNAB1 DLG1 AFDN MAP4K4 HSPA2 SLC4A8 WFS1 CAPN2 HIP1R GRIA4 NBEA MIB2 EIF5AL1 PEBP1 EIF5A MRPS9 SNCA | 2.95e-08 | 1139 | 272 | 29 | 36417873 | |
| Pubmed | CCDC30 ETFA PALMD IL1RL2 IGSF10 STARD9 PKD1 ADAMTS18 DLG1 ATP11C PLCB4 KLHL8 TRIM36 ANKRD40 GTF2A1L BAZ2B CAPN2 LAMA2 GRIA4 ERN2 TMEM87A MRPS9 | 3.00e-08 | 686 | 272 | 22 | 29987050 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DCAF1 THNSL1 MYO6 KDM3B MPDZ MELK NEDD8 WDR3 STK11 CTPS2 SHPRH DKC1 DLG1 KLHL8 MAP4K4 ANKRD52 KIF13B POLR1A CNOT10 TAF6L PRIM2 SUPT16H LRP1 ANKRD17 CDK1 DCAF11 EIF3H | 3.08e-08 | 1005 | 272 | 27 | 19615732 |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | GLS2 ACACA ACACB MRPS12 NT5C3A ETFA AS3MT IREB2 DNAJC27 WARS2 ACSL4 ADHFE1 CTPS2 TOMM40L ALDH1L2 MTCH2 SLC25A14 SHMT1 LARS2 RMDN2 ATP10D PARS2 GSR ABCB10 AASS PTCD2 MRPS9 | 7.06e-08 | 1047 | 272 | 27 | 18614015 |
| Pubmed | 1.26e-07 | 7 | 272 | 4 | 16059920 | ||
| Pubmed | TNIK MYO5A CKAP5 MPDZ TSC2 TWF1 KIAA0319 KCNAB1 DLG1 AFDN MAP4K4 KIF13B DNAJC13 SLC4A8 NACC1 ZNF618 KIF21A GRIA4 NBEA GRM3 SUPT16H LRP1 ANKRD17 DGKI TNS1 | 1.95e-07 | 963 | 272 | 25 | 28671696 | |
| Pubmed | SETX THNSL1 RPS6KA1 KDM3B MPDZ POP1 DLG1 AFDN DNA2 RNF128 MAP4K4 MIB2 ZDHHC17 SBNO2 CEMIP MARF1 MTR ANKRD17 IFT122 PLCE1 | 2.51e-07 | 650 | 272 | 20 | 38777146 | |
| Pubmed | DCAF1 TNIK DLG5 MYO5A MYO6 ETFA MPDZ DNAJC27 CMAS ITPR3 WDR3 PTPN13 PTPN14 POP1 DLG1 DNA2 MAP4K4 ANKRD52 HSPA2 HSPA5 DNAJC13 WFS1 SHMT1 CPD ZDHHC17 GSR LMAN1 ABCB10 SUPT16H MTR MRPS9 IFT122 | 2.53e-07 | 1487 | 272 | 32 | 33957083 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 SETX ACACA MYO5A GAPDH MYO6 CKAP5 CMAS BIRC6 MELK WDR3 ACSL4 PTPN14 POP1 DKC1 AFDN TAF2 ANKRD52 HSPA5 DNAJC13 POLR1A KIF21A CAPN2 HIP1R NCAPH PRIM2 SUPT16H ANKRD17 CDK1 CTPS1 | 3.32e-07 | 1353 | 272 | 30 | 29467282 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DLG5 GALE ACACA GAPDH ETFA CKAP5 KDM3B CMAS TWF1 ACSL4 DLG1 AFDN MTCH2 HSPA5 CNN3 DNAJC13 KIF21A CAPN2 HIP1R QTRT2 NCAPH PDLIM4 MYOF LMAN1 PEBP1 SUPT16H EIF5A LRP1 ANKRD17 CTPS1 | 4.12e-07 | 1367 | 272 | 30 | 32687490 |
| Pubmed | TNIK SETX ACACA GAPDH KDM3B BIRC6 MELK CNOT6 NEDD8 WDR3 FAT1 POP1 PLCB4 KLHL8 MTCH2 HSPA5 DNAJC13 KIF21A QTRT2 CPD APOB LARS2 GSR ZNF106 MYOF LMAN1 EIF5A CDK1 CTPS1 | 4.46e-07 | 1297 | 272 | 29 | 33545068 | |
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 11161802 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 11439001 | ||
| Pubmed | Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells. | 4.73e-07 | 3 | 272 | 3 | 16519677 | |
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 4.73e-07 | 3 | 272 | 3 | 15744052 | |
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 22544756 | ||
| Pubmed | 4.73e-07 | 3 | 272 | 3 | 36848144 | ||
| Pubmed | Mechanisms Regulating Acquisition of Platelet-Derived Factor V/Va by Megakaryocytes. | 4.73e-07 | 3 | 272 | 3 | 25800007 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | DCAF1 MYH11 ACACA MYO5A MYO6 CKAP5 ITPR3 DNAJC13 MYOF SUPT16H ANKRD17 | 6.36e-07 | 202 | 272 | 11 | 33005030 |
| Pubmed | DCAF1 MYO5A MYO6 CMAS TWF1 ITPR3 ACSL4 STK11 PTPN14 STRADA DKC1 HSPA2 ABCC1 HIP1R ZNF106 SUPT16H LRP1 PPP1R18 CDK1 | 7.47e-07 | 634 | 272 | 19 | 34591612 | |
| Pubmed | ACACB MYO1D MYO6 ETFA KDM3B ITPR3 NEK4 ACSL4 CHD6 TAF2 ANKRD52 FAT4 NACC1 SMARCAL1 NBEA ABCC6 AASS MRPS9 ANKRD17 | 8.20e-07 | 638 | 272 | 19 | 31182584 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DCAF1 IFT172 RPS6KA1 ETFA CKAP5 MPDZ NHLRC2 ITPR3 PTPN14 PTPRM DLG1 AFDN ANKRD52 MTCH2 HSPA5 CAPN2 QTRT2 CPD GSR LMAN1 EIF5A LRP1 ANKRD17 CDK1 | 8.73e-07 | 974 | 272 | 24 | 28675297 |
| Pubmed | SETX ACACA ACACB GAPDH MYO6 CCDC30 KDM3B BIRC6 WDR3 FAT1 PTPN13 DLG1 AFDN DCLRE1A FAT4 DNAJC13 NBEA APOB NCAPH PEBP1 MRPS9 | 1.02e-06 | 777 | 272 | 21 | 35844135 | |
| Pubmed | Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo. | 1.16e-06 | 11 | 272 | 4 | 21554947 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TNIK DLG5 ACACA ACACB MYO1D ETFA CKAP5 TUBA8 WDR3 PTPN14 DKC1 AFDN TAF2 MAP4K4 ANKRD52 HSPA2 CNN3 CPD PEBP1 AASS EIF5A SNCA | 1.21e-06 | 853 | 272 | 22 | 28718761 |
| Pubmed | ACACA ACACB CKAP5 BIRC6 NEDD8 PTPN13 CHD6 ANKRD52 COL6A1 DNAJC13 NACC1 LMAN1 TET1 LRP1 ANKRD17 | 1.27e-06 | 418 | 272 | 15 | 34709266 | |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | GLS2 ACACA ACACB MRPS12 NT5C3A ETFA AS3MT IREB2 DNAJC27 WARS2 ADHFE1 TOMM40L ALDH1L2 MTCH2 SHMT1 LARS2 ATP10D PARS2 GSR ABCB10 AASS PTCD2 MRPS9 | 1.30e-06 | 926 | 272 | 23 | 20877624 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 SETX ACACA KCTD8 CKAP5 KDM3B MPDZ TSC2 MELK LYST TWF1 NEK4 PTPN13 PTPN14 STARD9 AFDN MAP4K4 KIF13B ZNF106 AASS TET1 ANKRD17 | 1.41e-06 | 861 | 272 | 22 | 36931259 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ACACA GAPDH RPS6KA1 ETFA KDM3B IREB2 NHLRC2 BIRC6 TWF1 NEDD8 CTPS2 POP1 ANKRD40 HSPA5 KIF21A CAPN2 SHMT1 NCAPH AHSA1 GSR ATG3 PRIM2 SUPT16H EIF5A MTR CDK1 DCAF11 EIF3H SNCA CTPS1 | 1.48e-06 | 1455 | 272 | 30 | 22863883 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SETX ACACA GAPDH CKAP5 TSC2 BIRC6 IGSF10 POP1 PKD1 CHD6 HSPA5 FAT4 NACC1 BAZ2B ZNF618 KIF21A NBEA TAF6L CDK1 CTPS1 | 1.71e-06 | 736 | 272 | 20 | 29676528 |
| Pubmed | MEK2 is a kinase related to MEK1 and is differentially expressed in murine tissues. | 1.72e-06 | 12 | 272 | 4 | 8297798 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MYO1D GAPDH MYO6 ACSL4 STK11 FAT1 PTPN13 PKD1 HSPA2 HSPA5 COL6A1 DNAJC13 CAPN2 SHMT1 ABCC11 NOX3 AHSA1 GSR GSTA1 MYOF PEBP1 CDK1 EIF3H UEVLD | 1.82e-06 | 1016 | 272 | 24 | 19056867 |
| Pubmed | 1.88e-06 | 4 | 272 | 3 | 19122654 | ||
| Pubmed | 2.02e-06 | 48 | 272 | 6 | 8884266 | ||
| Pubmed | MYO6 CKAP5 STARD9 AFDN MTCH2 HSPA5 CNN3 CNOT10 NBEA CPD TMEM87A LMAN1 EIF5A ANKRD17 CDK1 | 3.05e-06 | 449 | 272 | 15 | 31732153 | |
| Pubmed | MYO1D MYO5A BIRC6 ITPR3 ACSL4 PTPN13 PTPN14 PTPRB PTPRM DLG1 TRIM36 ANKRD52 HSPA2 HSPA5 ABCC1 DNAJC13 NBEA CPD LMAN1 PRIM2 SUPT16H PPP1R18 CDK1 TNS1 | 3.14e-06 | 1049 | 272 | 24 | 27880917 | |
| Pubmed | DLG5 ACACA MYO5A GAPDH MYO6 CKAP5 KDM3B PTPN14 POP1 MAP4K4 NCAPH MYOF CDK1 CTPS1 | 3.73e-06 | 399 | 272 | 14 | 37536630 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | MYH11 MYO1D MYO5A GAPDH MYO6 TWF1 ACSL4 HSPA5 PTGES AHSA1 LGALS8 MYO1F EIF5A PPP1R18 CDK1 TNS1 MYBPC2 | 3.88e-06 | 580 | 272 | 17 | 35676659 |
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 4.20e-06 | 156 | 272 | 9 | 30409884 | |
| Pubmed | The PDK1-Rsk Signaling Pathway Controls Langerhans Cell Proliferation and Patterning. | 4.68e-06 | 5 | 272 | 3 | 26401001 | |
| Pubmed | Biological Relevance and Therapeutic Potential of the Hypusine Modification System. | 4.68e-06 | 5 | 272 | 3 | 26037925 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ACACA MYO1D MYO5A MYO6 CWC27 CKAP5 PTPN13 DKC1 DCLRE1A TAF2 CNN3 DNAJC13 POLR1A CNOT10 MYOF EIF5A MARF1 ANKRD17 EIF3H | 5.15e-06 | 724 | 272 | 19 | 36232890 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ACACA ACACB MYO5A ETFA CKAP5 TUBA8 TWF1 ACSL4 AFDN MAP4K4 HSPA2 MTCH2 CNN3 AHSA1 EIF5AL1 SUPT16H EIF5A CTPS1 | 6.02e-06 | 665 | 272 | 18 | 30457570 |
| Pubmed | 6.61e-06 | 89 | 272 | 7 | 23891004 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DLG5 MYO1D MYO5A GAPDH MYO6 CKAP5 CMAS F5 TWF1 ITPR3 WDR3 PTPN14 POP1 DLG1 HSPA5 NCAPH AHSA1 LGALS8 MYOF SUPT16H MRPS9 PPP1R18 ANKRD17 CDK1 EIF3H CTPS1 | 7.32e-06 | 1257 | 272 | 26 | 36526897 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | THNSL1 MYO1D MYO6 MRPS12 NT5C3A ETFA TSC2 CMAS BIRC6 WARS2 ITPR3 SPTBN5 WDR3 ACSL4 PTPN14 ALDH1L2 DKC1 MTCH2 CPD ZDHHC17 LARS2 RMDN2 LMAN1 ABCB10 PEBP1 AASS SUPT16H MTR MRPS9 | 7.34e-06 | 1496 | 272 | 29 | 32877691 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | DCAF1 TNIK MYO1D MYO5A MYO6 CWC27 TSC2 PTPN13 ATP11C MAP4K4 CPD MTR | 7.65e-06 | 313 | 272 | 12 | 38270169 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ACACA MYO1D GAPDH MYO6 ETFA CKAP5 WDR3 STARD9 DKC1 AFDN MYO18B MAP4K4 MTCH2 HSPA5 POLR1A APOB NCAPH AHSA1 GSR LMAN1 PEBP1 SUPT16H EIF5A MTR MRPS9 CDK1 EIF3H CTPS1 | 8.32e-06 | 1425 | 272 | 28 | 30948266 |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 8.85e-06 | 171 | 272 | 9 | 20201926 | |
| Pubmed | MYH11 MYO1D MYO5A GAPDH MYO6 CKAP5 CMAS TBC1D24 TWF1 SORCS2 SLC17A7 KCNQ2 DLG1 AFDN HSPA2 MTCH2 HSPA5 ACSL6 DNAJC13 WFS1 EIF5A2 NBEA GRM3 WDR37 PEBP1 MRPS9 PPP1R18 TNS1 | 8.98e-06 | 1431 | 272 | 28 | 37142655 | |
| Pubmed | 9.30e-06 | 6 | 272 | 3 | 15389876 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | TNIK MYH11 MYO5A GAPDH MYO6 RPS6KA1 TUBA8 KCNAB1 MAP4K4 HSPA2 HSPA5 ACSL6 STAB2 WFS1 KIF21A CAPN2 AHSA1 | 9.47e-06 | 621 | 272 | 17 | 22794259 |
| Pubmed | 1.03e-05 | 18 | 272 | 4 | 19896490 | ||
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 1.03e-05 | 18 | 272 | 4 | 18311135 | |
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | THNSL1 GLS2 MRPS12 NT5C3A ETFA WARS2 ACSL4 ADHFE1 CTPS2 TOMM40L ALDH1L2 DNA2 MTCH2 SLC25A14 QTRT2 LARS2 RMDN2 PARS2 GSR ABCB10 AASS FAM210B PTCD2 MRPS9 | 1.18e-05 | 1136 | 272 | 24 | 34800366 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | TNIK TBC1D24 FAT1 PTPN14 PTPRM DLG1 TAF2 MAP4K4 KIF13B ABCC1 SLC4A8 CPD APOB TMEM87A ATP10D PLXNC1 | 1.25e-05 | 569 | 272 | 16 | 30639242 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ACACA MYO5A GAPDH MYO6 ETFA CKAP5 MPDZ NHLRC2 AFDN HSPA2 HSPA5 CNN3 NACC1 SHMT1 NCAPH AHSA1 GSR PEBP1 SUPT16H EIF5A ANKRD17 CDK1 EIF3H CTPS1 | 1.42e-05 | 1149 | 272 | 24 | 35446349 |
| Pubmed | 1.62e-05 | 7 | 272 | 3 | 15883194 | ||
| Pubmed | Role of myosin VIIa and Rab27a in the motility and localization of RPE melanosomes. | 1.62e-05 | 7 | 272 | 3 | 15572405 | |
| Pubmed | Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity. | 1.62e-05 | 7 | 272 | 3 | 22510986 | |
| Pubmed | 1.62e-05 | 102 | 272 | 7 | 9734811 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK ACACA ACACB GAPDH MYO6 ETFA CKAP5 KDM3B TWF1 RASSF5 PTPN13 DKC1 MTCH2 CNN3 NACC1 NCAPH AHSA1 GSR PEBP1 ANKRD17 CTPS1 | 1.71e-05 | 934 | 272 | 21 | 33916271 |
| Pubmed | ACACA KDM3B HSPA5 CNOT10 HIP1R NBEA NCAPH TAF6L SUPT16H EIF5A CDK1 | 1.90e-05 | 288 | 272 | 11 | 23383273 | |
| Pubmed | DLG5 MYO1D GAPDH TWF1 STK11 FAT1 STRADA DLG1 MAP4K4 HSPA2 NACC1 SUPT16H CDK1 | 1.91e-05 | 401 | 272 | 13 | 25852190 | |
| Pubmed | DLG5 SETX KDM3B MELK TBC1D24 CNOT6 DNA2 MAP4K4 KIF21A HIP1R WDR37 NCAPH TET1 CAPRIN2 ANKRD17 | 2.12e-05 | 529 | 272 | 15 | 14621295 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 2.20e-05 | 72 | 272 | 6 | 10380929 | |
| Pubmed | TNIK KDM3B MPDZ NHLRC2 BIRC6 MELK NEK4 DLG1 DCLRE1A CHD6 MAP4K4 ABCC1 LMF1 POLR1A ZNF106 SCAP MTR CTPS1 | 2.21e-05 | 733 | 272 | 18 | 34672954 | |
| Pubmed | 2.40e-05 | 22 | 272 | 4 | 27582005 | ||
| Pubmed | 2.57e-05 | 8 | 272 | 3 | 27378146 | ||
| Pubmed | DCAF1 ABCA12 CMAS SOWAHC NEDD8 FCSK FAT1 PTPN14 TAF2 DNA2 ANKRD52 NACC1 ZNF618 FAT3 QTRT2 WDR37 PARS2 TAF6L CAPRIN2 SUPT16H LRP1 MTR ANKRD17 | 2.66e-05 | 1116 | 272 | 23 | 31753913 | |
| Pubmed | DLG5 THNSL1 AS3MT CDH23 NHLRC2 DCLRE1A SLC16A9 MYOF FBH1 TET1 SORCS3 CDK1 PLCE1 | 2.73e-05 | 415 | 272 | 13 | 16385451 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | GAPDH MRPS12 TSC2 NEK4 IGSF10 FAT1 HSPA2 MTCH2 HSPA5 ALG12 COL6A1 ABCC1 FAT4 WFS1 PTGES CPD TMEM87A GSR MYOF SCAP LMAN1 LRP1 LTBP3 CERS1 | 2.89e-05 | 1201 | 272 | 24 | 35696571 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | CFAP251 ABCA13 CWC27 CKAP5 CDH23 F5 FAT1 ADAMTS18 MYO18B DNAJC13 MIB2 ATP10A | 3.13e-05 | 361 | 272 | 12 | 26167880 |
| Pubmed | TNIK ACACA ACACB TBC1D24 PTPN13 PTPN14 CTPS2 PTPRM DLG1 MAP4K4 ABCC1 CPD WDR37 | 3.16e-05 | 421 | 272 | 13 | 36976175 | |
| Pubmed | 3.22e-05 | 77 | 272 | 6 | 10835267 | ||
| Pubmed | ACACA GAPDH KDM3B MPDZ PTPN13 PTPN14 DLG1 AFDN TAF2 MAP4K4 HSPA5 CNN3 NCAPH TET1 CTPS1 | 3.25e-05 | 549 | 272 | 15 | 38280479 | |
| Pubmed | DCAF1 THNSL1 ETFA KDM3B BIRC6 WARS2 ALDH1L2 MTCH2 SHMT1 QTRT2 CPD LARS2 PARS2 ABCB10 AASS PRIM2 LRP1 | 3.34e-05 | 686 | 272 | 17 | 28380382 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.45e-05 | 203 | 272 | 9 | 22083510 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 4.01e-05 | 80 | 272 | 6 | 10716726 | |
| Pubmed | MYO6 CWC27 CKAP5 NEDD8 WDR3 PRDM10 AFDN HSPA5 CNN3 CNOT10 CAPN2 CPD AHSA1 ABCB10 CTPS1 | 4.07e-05 | 560 | 272 | 15 | 35241646 | |
| Pubmed | TWF1 NEDD8 SPTBN5 POP1 DKC1 MYO18B DNAJC13 POLR1A EIF5A2 APOB GSR FAM222A NR5A2 MRPS9 | 4.20e-05 | 496 | 272 | 14 | 31343991 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 4.56e-05 | 262 | 272 | 10 | 36880596 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | TNIK MYO5A MYO6 CDH23 NHLRC2 MELK TWF1 CNOT6 WDR3 ACSL4 PIK3CB KIF13B ADAP1 SMARCAL1 WDR37 NCAPH RHD ZNF106 TET1 CAPRIN2 DCAF11 EIF3H FGGY UEVLD | 4.91e-05 | 1242 | 272 | 24 | 30973865 |
| Pubmed | DLG5 GAPDH MYO6 CKAP5 MPDZ PTPN13 DLG1 AFDN MAP4K4 HSPA5 CNN3 CPD LMAN1 EIF5A ANKRD17 CDK1 CTPS1 | 4.94e-05 | 708 | 272 | 17 | 39231216 | |
| Pubmed | ACACA MRPS12 ETFA TSC2 NHLRC2 BIRC6 PRDM10 PIK3CB STRADA DKC1 MAP4K4 HSPA5 ALG12 DET1 NACC1 SMARCAL1 CENPO GSR TAF6L ZNF106 SCAP SUPT16H NR5A2 MRPS9 ANKRD17 | 5.12e-05 | 1327 | 272 | 25 | 32694731 | |
| Pubmed | 5.45e-05 | 10 | 272 | 3 | 15919184 | ||
| Pubmed | 5.45e-05 | 10 | 272 | 3 | 1981995 | ||
| Pubmed | 5.45e-05 | 10 | 272 | 3 | 15579147 | ||
| Pubmed | ACACB MPDZ TSC2 BIRC6 NEK4 RASSF5 PTPN13 PTPN14 AFDN MAP4K4 ANKRD52 NACC1 CNOT10 | 5.70e-05 | 446 | 272 | 13 | 24255178 | |
| Pubmed | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. | DCAF1 CWC27 MPDZ RASSF5 PTPN13 PTPN14 DKC1 DLG1 TAF2 PPP1R18 | 5.87e-05 | 270 | 272 | 10 | 24366813 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ACACA GAPDH MYO6 NT5C3A ETFA TSC2 BIRC6 WDR3 CTPS2 DKC1 DNA2 HSPA2 HSPA5 POLR1A SHMT1 EIF5A2 QTRT2 AHSA1 TAF6L AASS EIF5A MTR CDK1 CTPS1 | 5.91e-05 | 1257 | 272 | 24 | 37317656 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | IREB2 BIRC6 PTPN13 PTPRM DLG1 AFDN PLCB4 MAP4K4 ALG12 ABCC1 TMEM87A LGALS8 ABCB10 PRIM2 PTCD2 CERS1 UEVLD | 5.96e-05 | 719 | 272 | 17 | 35337019 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MYH11 MYO6 NT5C3A TSC2 ITPR3 CTPS2 HSPA2 MTCH2 ABCC1 POLR1A WFS1 CAPN2 CPD ZDHHC17 SCAP LMAN1 ABCB10 MTR ANKRD17 CERS1 | 6.01e-05 | 942 | 272 | 20 | 31073040 |
| Pubmed | MYO6 ABCA13 ABCA12 IFT172 TUBA8 NEK4 STARD9 L3HYPDH HSPA2 FAT4 EIF5A2 APOB SPAG17 UEVLD | 6.02e-05 | 513 | 272 | 14 | 25798074 | |
| Pubmed | Epinephrine-induced hyperpolarization of pancreatic islet cells is sensitive to PI3K-PDK1 signaling. | 6.09e-05 | 2 | 272 | 2 | 19716369 | |
| Pubmed | 6.09e-05 | 2 | 272 | 2 | 29491408 | ||
| Pubmed | Reduced intestinal and renal amino acid transport in PDK1 hypomorphic mice. | 6.09e-05 | 2 | 272 | 2 | 17077298 | |
| Pubmed | 3'Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium. | 6.09e-05 | 2 | 272 | 2 | 17077284 | |
| Cytoband | 5q31 | 6.03e-06 | 115 | 272 | 7 | 5q31 | |
| Cytoband | 16p13.1 | 2.08e-04 | 4 | 272 | 2 | 16p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 2.56e-04 | 426 | 272 | 10 | chr16p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 2.57e-04 | 147 | 272 | 6 | chr15q15 | |
| Cytoband | 1p22-p21 | 3.46e-04 | 5 | 272 | 2 | 1p22-p21 | |
| Cytoband | 1p12 | 4.30e-04 | 25 | 272 | 3 | 1p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 4.39e-04 | 298 | 272 | 8 | chr5q31 | |
| GeneFamily | Cadherin related | 5.64e-07 | 17 | 183 | 5 | 24 | |
| GeneFamily | ATPase phospholipid transporting | 1.27e-05 | 15 | 183 | 4 | 1210 | |
| GeneFamily | ATP binding cassette subfamily C | 2.71e-04 | 13 | 183 | 3 | 807 | |
| GeneFamily | WD repeat domain containing | CFAP251 IFT172 LYST WDR3 KIF21A NBEA WDR37 SCAP IFT122 DCAF11 | 3.47e-04 | 262 | 183 | 10 | 362 |
| GeneFamily | C2 domain containing|Calpains | 4.24e-04 | 15 | 183 | 3 | 975 | |
| GeneFamily | Clustered protocadherins | 4.73e-04 | 64 | 183 | 5 | 20 | |
| GeneFamily | Ankyrin repeat domain containing | 8.22e-04 | 242 | 183 | 9 | 403 | |
| GeneFamily | PDZ domain containing | 9.15e-04 | 152 | 183 | 7 | 1220 | |
| GeneFamily | Acyl-CoA synthetase family | 2.23e-03 | 26 | 183 | 3 | 40 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.49e-03 | 181 | 183 | 7 | 694 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 2.74e-03 | 8 | 183 | 2 | 658 | |
| GeneFamily | Myosins, class I | 2.74e-03 | 8 | 183 | 2 | 1097 | |
| GeneFamily | Transglutaminases | 3.50e-03 | 9 | 183 | 2 | 773 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 3.50e-03 | 9 | 183 | 2 | 1230 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 4.35e-03 | 10 | 183 | 2 | 1178 | |
| GeneFamily | UPF1 like RNA helicases | 5.28e-03 | 11 | 183 | 2 | 1169 | |
| GeneFamily | CCR4-NOT transcription complex | 5.28e-03 | 11 | 183 | 2 | 1023 | |
| GeneFamily | Fibronectin type III domain containing | 5.82e-03 | 160 | 183 | 6 | 555 | |
| Coexpression | GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_UP | ITPR3 SLC17A7 MAP4K4 WFS1 PON3 DNAAF9 ZDHHC17 LGALS8 MYOF FAM210B EIF3H | 8.45e-06 | 200 | 272 | 11 | M6363 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SETX CKAP5 KDM3B MELK NEK4 ACSL4 FAT1 PTPN13 PTPRM DLG1 PLCB4 ABCC1 DNAJC13 BAZ2B ZDHHC17 LARS2 WDR37 TMEM87A CEMIP MYOF PRIM2 MTR ANKRD17 PLCE1 | 1.14e-05 | 856 | 272 | 24 | M4500 |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | CAPN9 TNIK DLG5 MYH11 ACACA ACACB MYO6 ABCA12 KCNAB1 TRIM36 HSPA2 ALG12 KIF13B LMF1 SLC4A8 NBEA CPD CPE ABCC6 LGALS8 IFT122 | 1.49e-05 | 699 | 272 | 21 | M4960 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN | PLCB4 RNF128 HSPA2 HIP1R EIF5A2 ATP10A CXCR6 CD28 MYO1F CDK1 | 2.30e-05 | 183 | 272 | 10 | M8886 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | DLG5 ACACB MYO6 PIGA PTPRM TAF2 COL6A1 ABCC1 DNAJC13 BAZ2B CAPN2 ATP10A TMEM87A LGALS8 MYOF PLXNC1 CAPRIN2 SUPT16H LRP1 MTR CDK1 CTPS1 | 2.96e-05 | 790 | 272 | 22 | M12490 |
| Coexpression | IBRAHIM_NRF1_UP | GAPDH CMAS NEK4 WDR3 FAT2 POP1 DKC1 TAF2 MAP4K4 HSPA5 DNMT3B AHSA1 ATP10D LMAN1 EIF3H | 3.73e-05 | 420 | 272 | 15 | M42509 |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN | 4.90e-05 | 200 | 272 | 10 | M8208 | |
| Coexpression | GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN | 4.90e-05 | 200 | 272 | 10 | M7961 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 4.90e-05 | 200 | 272 | 10 | M6513 | |
| Coexpression | GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP | 4.90e-05 | 200 | 272 | 10 | M9273 | |
| Coexpression | GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN | 4.90e-05 | 200 | 272 | 10 | M9211 | |
| Coexpression | DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP | 7.16e-05 | 22 | 272 | 4 | M34033 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | RHOJ PALMD IL1RL2 IGSF10 L3HYPDH COL6A1 FAT3 GRIA4 MYOF LRP1 LSP1 | 9.92e-06 | 168 | 268 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | TNIK MYH11 RHOJ PALMD IL1RL2 IGSF10 PTPN13 KCNAB1 L3HYPDH RNF128 PAPPA2 COL6A1 FAT4 POLR1A ZNF618 FAT3 GRIA4 RMDN2 ATP10D MYOF PLXNC1 CAPRIN2 LRP1 MTR LSP1 | 2.91e-05 | 797 | 268 | 25 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 3.02e-05 | 156 | 268 | 10 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | DLG5 CKAP5 SLC18B1 IGSF10 CTPS2 STARD9 CYP7B1 ACSBG2 ALG12 COL6A1 FAT4 ZNF618 PTGES LAMA2 NBEA ZDHHC17 LGALS8 FBH1 FAM210B CNTN3 LSP1 | 3.21e-05 | 607 | 268 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | NAT8L DLG5 GAPDH IFT172 CDH23 TSC2 ADHFE1 PTPN13 PIGA PKD1 SORCS2 ADAMTS18 DCLRE1A ATP8B3 ABCC1 LMF1 DET1 PCDHGB6 BAZ2B ZNF618 FAT3 PTGES SHMT1 NBEA MIB2 ZDHHC17 TAF6L LMAN1 AASS FAM222A CNTN3 CERS1 SNCA | 4.58e-05 | 1245 | 268 | 33 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | MYH11 ACACA RHOJ IL1RL2 IGSF10 RASSF5 FAT1 SORCS2 PAPPA2 COL6A1 FAT3 LAMA2 PON3 GRIA4 RMDN2 GSTA1 MYOF LMAN1 SLC26A7 PLXNC1 LRP1 SORCS3 LSP1 PLCE1 | 4.96e-05 | 773 | 268 | 24 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | TNIK DLG5 SETX CKAP5 SLC18B1 IGSF10 CTPS2 STARD9 CYP7B1 ACSBG2 DNA2 COL6A1 FAT4 ZNF618 PTGES LAMA2 NBEA ZDHHC17 NCAPH FBH1 FAM210B CNTN3 LSP1 | 7.62e-05 | 744 | 268 | 23 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 ABCA12 CAPN8 FAT1 KCNQ2 FAT4 STAB2 ZAN FAT3 APOB UNC13C MYOM2 SPAG17 MYO16 PLCE1 | 5.74e-13 | 184 | 272 | 15 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 ABCA12 CAPN8 FAT1 KCNQ2 FAT4 STAB2 ZAN FAT3 APOB UNC13C MYOM2 SPAG17 MYO16 PLCE1 | 5.74e-13 | 184 | 272 | 15 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 ABCA12 CAPN8 FAT1 KCNQ2 FAT4 STAB2 ZAN FAT3 APOB UNC13C MYOM2 SPAG17 MYO16 PLCE1 | 5.74e-13 | 184 | 272 | 15 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | SETX MPDZ PALMD PTPRB PTPRM AFDN PLCB4 MAP4K4 FAT4 BAZ2B MFSD4A NR5A2 | 4.17e-09 | 200 | 272 | 12 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SETX MPDZ PALMD BIRC6 PTPRB PTPRM AFDN PLCB4 FAT4 BAZ2B MFSD4A NR5A2 | 4.17e-09 | 200 | 272 | 12 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 ABCA12 NALCN ZAN FAT3 GRIA4 LARS2 SORCS3 DGKI UNC13C SNCA | 8.00e-09 | 169 | 272 | 11 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MYH11 NALCN KCNAB1 PLCB4 COL6A1 LAMA2 CPE ATP10A RAB7B TNS1 PLCE1 | 1.83e-08 | 183 | 272 | 11 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | MYO5A MPDZ NALCN ALDH1L2 CYP7B1 KLHL8 FAT4 LAMA2 ATP10D ZNF106 CYP2U1 | 1.94e-08 | 184 | 272 | 11 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | MYH11 MELK NDST3 PTPRB SORCS2 DNA2 FAT3 CENPO SHMT1 NCAPH CDK1 | 2.70e-08 | 190 | 272 | 11 | e83fa8b711aa79a1767818474f1c193b674b1c31 |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RHOJ MYO6 PALMD PTPRB PTPRM AFDN PLCB4 FAT4 MFSD4A NR5A2 LRRC36 | 3.00e-08 | 192 | 272 | 11 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RHOJ MYO6 PALMD PTPRB PTPRM AFDN PLCB4 FAT4 MFSD4A NR5A2 LRRC36 | 3.00e-08 | 192 | 272 | 11 | 04f5a2e3dd6beff027b89d66eefdd92036e041af |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | RHOJ MYO6 MPDZ PALMD CYP7B1 PLCB4 CNN3 CAPN2 LAMA2 ATP10A TNS1 | 4.56e-08 | 200 | 272 | 11 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | RHOJ MYO6 MPDZ PALMD CYP7B1 PLCB4 CNN3 CAPN2 LAMA2 ATP10A TNS1 | 4.56e-08 | 200 | 272 | 11 | 68fce28690246895fd33354b30960ebcc31aa4cc |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | RHOJ MYO6 MPDZ PALMD CYP7B1 PLCB4 CNN3 CAPN2 LAMA2 ATP10A TNS1 | 4.56e-08 | 200 | 272 | 11 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | RHOJ MYO6 MPDZ PALMD CYP7B1 PLCB4 CNN3 CAPN2 LAMA2 ATP10A TNS1 | 4.56e-08 | 200 | 272 | 11 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | RHOJ MYO6 MPDZ PALMD CYP7B1 PLCB4 CNN3 CAPN2 LAMA2 ATP10A TNS1 | 4.56e-08 | 200 | 272 | 11 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DLG5 MYO1D MYO6 ABCA13 FAT2 PTPN13 AFDN CNN3 KIF21A MFSD4A MYOF | 4.56e-08 | 200 | 272 | 11 | ecbe89ff95d046155b984c8c150e0b9e7278f839 |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | RHOJ MYO6 MPDZ PALMD CYP7B1 PLCB4 CNN3 CAPN2 LAMA2 ATP10A TNS1 | 4.56e-08 | 200 | 272 | 11 | 7136936d05ab344a560cf159684c881063b5430d |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | ACACA CAPN8 FAT1 PTPN13 PTPN14 SORCS2 KCNQ2 MFSD4A CNTN3 UNC13C | 2.10e-07 | 184 | 272 | 10 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | CAPN9 ACACA CAPN8 FAT1 PTPN13 SORCS2 PON3 MFSD4A AASS UNC13C | 2.21e-07 | 185 | 272 | 10 | 673f0c688ae6984bc8027df2da335787924f4137 |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.32e-07 | 186 | 272 | 10 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-07 | 191 | 272 | 10 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MYH11 FAT1 PTPRM KCNAB1 ATP11C GRIA4 SYTL5 UNC13C GRIP2 MYO16 | 3.27e-07 | 193 | 272 | 10 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MYO1D PALMD PTPRB PTPRM PLCB4 FAT4 BAZ2B MFSD4A NR5A2 LRRC36 | 3.27e-07 | 193 | 272 | 10 | e1d546165dcc2392f540162206852c4717d7306f |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | MYH11 FAT1 PTPRM KCNAB1 ATP11C GRIA4 SYTL5 UNC13C GRIP2 MYO16 | 3.27e-07 | 193 | 272 | 10 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.27e-07 | 193 | 272 | 10 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.27e-07 | 193 | 272 | 10 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-07 | 194 | 272 | 10 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-07 | 194 | 272 | 10 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.43e-07 | 194 | 272 | 10 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 3.43e-07 | 194 | 272 | 10 | f0ababe8daa57f6827a3e2e72c884d9e8b2687a3 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.77e-07 | 196 | 272 | 10 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.13e-07 | 198 | 272 | 10 | 99d6a64f3410dae3019161feef20a8f06081a24b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | GALE KCTD8 PALMD ALDH1L2 PLCB4 SLC4A8 SLC16A9 CPD ERN2 CNTN3 | 4.53e-07 | 200 | 272 | 10 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.53e-07 | 200 | 272 | 10 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.53e-07 | 200 | 272 | 10 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.53e-07 | 200 | 272 | 10 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.53e-07 | 200 | 272 | 10 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | mild_COVID-19-RBC|World / disease group, cell group and cell class (v2) | 6.22e-07 | 117 | 272 | 8 | 85210be67ddc31903764b7fa6d7029d9656753d3 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.77e-07 | 161 | 272 | 9 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | mild_COVID-19-RBC|mild_COVID-19 / disease group, cell group and cell class (v2) | 7.54e-07 | 120 | 272 | 8 | cccea760901558ec18d5cbb71c7971c5a51da571 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.32e-07 | 165 | 272 | 9 | 1d0f60bf47a40ac916f0fcb5532a968742a0edbb | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 169 | 272 | 9 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.18e-06 | 172 | 272 | 9 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-06 | 176 | 272 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.56e-06 | 178 | 272 | 9 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-06 | 180 | 272 | 9 | 1bc01bb76d0d3f8db74f9244436d3e6d6015ed5d | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 180 | 272 | 9 | 54e3f289a37d4cfbfca4fb284c3b52e9c7d9da97 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 180 | 272 | 9 | bfc8568d57034dd9c9e07edae94479a48ca0706d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-06 | 180 | 272 | 9 | 2a28fbfe10a340c8662c2c8be33792f41fc09088 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-06 | 180 | 272 | 9 | 12f3c4c4aa7fe03c0ef847bd4d4942c808015f5f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-06 | 181 | 272 | 9 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-06 | 182 | 272 | 9 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.15e-06 | 185 | 272 | 9 | c4bf3ac684c1a8876b51f7af4d3a62dc47e961ee | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.35e-06 | 187 | 272 | 9 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.45e-06 | 188 | 272 | 9 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 2.45e-06 | 188 | 272 | 9 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.56e-06 | 189 | 272 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|World / Lineage, cell class and subclass | 2.56e-06 | 189 | 272 | 9 | 826457adac7477102f86aceb97a8b77929b3e6f9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-06 | 190 | 272 | 9 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells|World / Lineage, cell class and subclass | 2.68e-06 | 190 | 272 | 9 | 6c7e016a9b425ee9418acd4fe96b9779fe7bd39a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.79e-06 | 191 | 272 | 9 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.91e-06 | 192 | 272 | 9 | 6ace9a34ed264583042156ed61c2cb3504a331d2 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.04e-06 | 193 | 272 | 9 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.04e-06 | 193 | 272 | 9 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.17e-06 | 194 | 272 | 9 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-06 | 194 | 272 | 9 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.17e-06 | 194 | 272 | 9 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-06 | 194 | 272 | 9 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.17e-06 | 194 | 272 | 9 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.17e-06 | 194 | 272 | 9 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.17e-06 | 194 | 272 | 9 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.31e-06 | 195 | 272 | 9 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.45e-06 | 196 | 272 | 9 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.45e-06 | 196 | 272 | 9 | 51c48944149a89b98011a50fe81ca6664d5f0d44 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.45e-06 | 196 | 272 | 9 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | 15-Trachea-RBC-RBC|Trachea / Age, Tissue, Lineage and Cell class | 3.45e-06 | 196 | 272 | 9 | 511bfc06c34d5add2ae561cca463d1e4e2d43e20 | |
| ToppCell | 15-Trachea-RBC|Trachea / Age, Tissue, Lineage and Cell class | 3.45e-06 | 196 | 272 | 9 | bf2670e5ae996a19987bc70aa5a37d133db789eb | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.45e-06 | 196 | 272 | 9 | 2aeb792e7685e33e3543a6974be790980a41ed8c | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-sinusoidal_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.60e-06 | 197 | 272 | 9 | f1080d93acf1a4756d2f2c8cabd1fb50bc7bcd09 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.60e-06 | 197 | 272 | 9 | b71da7f2fd8d526fb6e5d57e60fc08acdd8dbefb | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.75e-06 | 198 | 272 | 9 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | moderate-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.75e-06 | 198 | 272 | 9 | 7ecce5e266bb08797088cc8f8309e0c7b48df5c9 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.75e-06 | 198 | 272 | 9 | 5d42f4fda2081ea3e9f62a00e7eea702e0d0be7d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 198 | 272 | 9 | 4448d13511485a44fe7b549e4b8b6ad7637db624 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.75e-06 | 198 | 272 | 9 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-06 | 199 | 272 | 9 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-06 | 199 | 272 | 9 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | PSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.90e-06 | 199 | 272 | 9 | 58dcb0eedafa8629585dc99e53147e2287f49689 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.04e-06 | 150 | 272 | 8 | 744050a1b665c6989f37141348af3df7579a73c9 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.07e-06 | 200 | 272 | 9 | e90155498397524b812c46f2412320230b445bb6 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.07e-06 | 200 | 272 | 9 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | 10x5'v1-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.07e-06 | 200 | 272 | 9 | e786544cf6f891550c4be55ebb4928c92297b504 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.07e-06 | 200 | 272 | 9 | 2488aa12970a43a5af352e2c36c73884d73a1cc5 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.38e-06 | 70 | 272 | 6 | 8d6bdf2e773e894a0db39fdff1fafc2474e03fcf | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.93e-06 | 158 | 272 | 8 | 50df52d64d07178975563abd98ce4fddb9f2f7ef | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-06 | 160 | 272 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-06 | 160 | 272 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | ILEUM-non-inflamed-(3)_pDC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.45e-06 | 163 | 272 | 8 | bc5411702badab39143905aa51676b4bbfad2041 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.15e-06 | 165 | 272 | 8 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| Drug | hydroxyl radicals | GLS2 GAPDH RHOJ CYP8B1 NT5C3A UROC1 F5 ADHFE1 PTPN13 PTPN14 CTPS2 BOK PTPRB PIGA PTPRM ALDH1L2 SLC17A7 CYP7B1 ATP11C PLCB4 ATP8B3 ABCC1 ENPP7 SHMT1 PON3 NOX4 CPD ATP10D GSR GSTA1 GSTA2 SLC26A7 AASS LRP1 MTR CYP2U1 CDK1 CTPS1 SPAG17 | 1.83e-07 | 1341 | 269 | 39 | CID000000961 |
| Drug | pyrophosphate | MYH11 MYO1D MYO5A GAPDH MYO6 PDPK1 CMAS WARS2 ACSL4 ADHFE1 PIK3CB AFDN PLCB4 MYO18B ALG12 ACSL6 COL6A1 GTF2A1L POLR1A SHMT1 LARS2 PARS2 PEBP1 MTR PLCE1 | 2.88e-07 | 654 | 269 | 25 | CID000001023 |
| Drug | Glutathione | GAPDH AS3MT ACSL4 HSPA5 ABCC1 PON3 ABCC6 GSR GSTA1 GSTA2 PRIM2 TET1 LRP1 MTR SNCA CTPS1 | 3.24e-06 | 340 | 269 | 16 | ctd:D005978 |
| Drug | Raloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; HL60; HT_HG-U133A | GLS2 MYO6 PTPRB AFDN OSBP2 ALG12 COL6A1 LMF1 TNFSF18 PCDHGB6 ABCC6 CD28 | 3.25e-06 | 192 | 269 | 12 | 2738_UP |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; MCF7; HT_HG-U133A | CAPN9 DCAF1 F5 SPTBN5 AFDN KIF13B TNFSF18 SBNO2 LGALS8 CXCR6 EPB42 PLCE1 | 4.02e-06 | 196 | 269 | 12 | 2295_UP |
| Drug | glutathione reduced | GLS2 GAPDH AS3MT IREB2 LYST ADHFE1 CYP7B1 ABCC1 PTGES ABCC11 NOX4 CPD ZDHHC17 ABCC6 GSR GSTA1 GSTA2 AASS MTR TGM7 | 6.29e-06 | 534 | 269 | 20 | CID000000745 |
| Drug | AC1L9K72 | CYP8B1 ETFA DGKQ LYST SPTBN5 PLCB4 ENPP7 VPS8 APOB ABCC6 ATG3 PEBP1 DGKI PLCE1 | 1.01e-05 | 290 | 269 | 14 | CID000446872 |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | ACACA LYST PIK3CB HSPA5 PTGES EIF5A2 CPE CEMIP LMAN1 FAM210B DCAF11 | 1.56e-05 | 188 | 269 | 11 | 7124_UP |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A | DLG5 ACACB LYST SLC17A7 OSBP2 TRIM36 COL6A1 CAPN2 GRM3 PDLIM4 LMAN1 | 1.81e-05 | 191 | 269 | 11 | 5917_UP |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | MPDZ PTPRB PAPPA2 STAB2 LAMA2 PDLIM4 TAF6L AASS LRP1 SNCA TNS1 | 2.19e-05 | 195 | 269 | 11 | 3821_DN |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | TNIK ACACB TSC2 NHLRC2 DLG1 CYP7B1 DCLRE1A CPE ERN2 MYOF FAM210B | 2.30e-05 | 196 | 269 | 11 | 5827_DN |
| Drug | Panthenol (D) [81-13-0]; Up 200; 19.4uM; PC3; HT_HG-U133A | ACACB MPDZ PALMD LYST CAPN2 CENPO CPD ERN2 SBNO2 PDLIM4 LMAN1 | 2.41e-05 | 197 | 269 | 11 | 1802_UP |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; PC3; HT_HG-U133A | DLG5 MRPS12 IREB2 PIK3CB COL6A1 ABCC1 HIP1R EIF5A2 ERN2 GSR LMAN1 | 2.41e-05 | 197 | 269 | 11 | 5872_DN |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; PC3; HT_HG-U133A | GLS2 STK11 CYP7B1 AFDN OSBP2 ALG12 COL6A1 LMF1 CENPO SBNO2 LRP1 | 2.41e-05 | 197 | 269 | 11 | 6629_DN |
| Drug | Delcorine; Up 200; 8.4uM; HL60; HT_HG-U133A | STK11 PTPRM SLC17A7 KCNAB1 LMF1 STAB2 LARS2 ATP10A ATG3 DGKI SNCA | 2.52e-05 | 198 | 269 | 11 | 2178_UP |
| Drug | Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; HL60; HT_HG-U133A | MYH11 STK11 SLC17A7 HSPA2 SLC4A8 SHMT1 PON3 APOB SNCA TNS1 PLCE1 | 2.52e-05 | 198 | 269 | 11 | 2708_UP |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | PDPK1 ACSL4 STK11 PTPN14 PTPRM TRIM36 KIF13B LMF1 CENPO ERN2 LMAN1 | 2.64e-05 | 199 | 269 | 11 | 6974_UP |
| Drug | Protoveratrine A [143-57-7]; Down 200; 5uM; PC3; HT_HG-U133A | MRPS12 PIK3CB AFDN ALG12 KIF13B FAT4 SBNO2 CEMIP AASS LRP1 TNS1 | 2.64e-05 | 199 | 269 | 11 | 6618_DN |
| Drug | Chlorambucil | 2.64e-05 | 50 | 269 | 6 | ctd:D002699 | |
| Drug | Cibacron blue-agarose | 2.68e-05 | 101 | 269 | 8 | CID000172468 | |
| Drug | formycin triphosphate | 2.97e-05 | 51 | 269 | 6 | CID000122274 | |
| Drug | 6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one | 3.18e-05 | 6 | 269 | 3 | ctd:C438505 | |
| Drug | Phthalic Acids | ACACA IREB2 MELK LYST CNOT6 ACSL4 SHPRH ANKRD52 MTCH2 CNN3 FAT4 DET1 NACC1 KIF21A EIF5A2 GRIA4 CPE TMEM87A GSTA1 LMAN1 PEBP1 MYOM2 TNS1 | 4.07e-05 | 762 | 269 | 23 | ctd:D010795 |
| Disease | Colorectal Carcinoma | ACACA GAPDH ABCA13 ABCA12 F5 NDST3 ACSL4 STK11 FAT1 TOMM40L ADAMTS18 ATP11C ABCC1 APOB CPE ABCC6 ABCB10 LRP1 EIF3H SPAG17 | 7.23e-06 | 702 | 267 | 20 | C0009402 |
| Disease | Schizophrenia | TNIK ABCA13 NDST3 PIK3CB SLC17A7 KCNQ2 DLG1 DNMT3B ACSL6 LAMA2 SHMT1 GRIA4 GRM3 LARS2 RHD SBNO2 GSTA1 SLC26A7 TET1 LRP1 MTR MYO16 | 2.03e-05 | 883 | 267 | 22 | C0036341 |
| Disease | Seizures | 3.24e-05 | 218 | 267 | 10 | C0036572 | |
| Disease | mental development measurement | 7.14e-05 | 25 | 267 | 4 | EFO_0008230 | |
| Disease | Polycystic kidneys, severe infantile with tuberous sclerosis | 8.16e-05 | 2 | 267 | 2 | C1838327 | |
| Disease | factor V deficiency (is_implicated_in) | 8.16e-05 | 2 | 267 | 2 | DOID:2216 (is_implicated_in) | |
| Disease | Nonsyndromic Deafness | 9.54e-05 | 81 | 267 | 6 | C3711374 | |
| Disease | Bipolar Disorder | ABCA13 TUBA8 NEK4 NDST3 STARD9 SORCS2 SLC17A7 KCNQ2 HSPA5 WFS1 HIP1R GRM3 LARS2 MTR | 1.28e-04 | 477 | 267 | 14 | C0005586 |
| Disease | Squamous cell carcinoma of esophagus | 2.30e-04 | 95 | 267 | 6 | C0279626 | |
| Disease | progressive familial intrahepatic cholestasis (implicated_via_orthology) | 2.43e-04 | 3 | 267 | 2 | DOID:0070221 (implicated_via_orthology) | |
| Disease | Lewy body dementia | 4.20e-04 | 39 | 267 | 4 | EFO_0006792 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 4.67e-04 | 71 | 267 | 5 | EFO_0007878, EFO_0007979 | |
| Disease | autosomal recessive congenital ichthyosis 4B (implicated_via_orthology) | 4.84e-04 | 4 | 267 | 2 | DOID:0060713 (implicated_via_orthology) | |
| Disease | CD166 antigen measurement | 4.84e-04 | 4 | 267 | 2 | EFO_0020245 | |
| Disease | cortical thickness | TNIK GLS2 NUP210L AS3MT CMAS WARS2 PKD1 ADAMTS18 KLHL8 TRIM36 MTCH2 FAT3 SMARCAL1 LAMA2 DNAAF9 ZNF106 PLXNC1 LRP1 DGKI TNS1 MYO16 PLCE1 | 5.46e-04 | 1113 | 267 | 22 | EFO_0004840 |
| Disease | hereditary spastic paraplegia 76 (implicated_via_orthology) | 8.01e-04 | 5 | 267 | 2 | DOID:0110821 (implicated_via_orthology) | |
| Disease | muscular disease (implicated_via_orthology) | 8.01e-04 | 5 | 267 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | linoleoylcarnitine (C18:2) measurement | 8.01e-04 | 5 | 267 | 2 | EFO_0800338 | |
| Disease | pulse pressure measurement | MYH11 CCDC30 ETFA CKAP5 FCSK PKD1 DCLRE1A MTCH2 DNMT3B PAPPA2 COL6A1 ZNF618 FAT3 NOX4 NBEA SLC26A7 PLXNC1 TET1 PTCD2 LRP1 SORCS3 LSP1 LTBP3 FGGY PLCE1 | 9.22e-04 | 1392 | 267 | 25 | EFO_0005763 |
| Disease | Sarcosine measurement | 1.13e-03 | 23 | 267 | 3 | EFO_0021668 | |
| Disease | cortical surface area measurement | TNIK GLS2 ETFA WARS2 CNOT6 PKD1 ADAMTS18 MAP4K4 MTCH2 ACSL6 DNAJC13 ZAN BAZ2B FAT3 CAPN2 LAMA2 DNAAF9 ZNF106 CD28 DGKI SPAG17 TNS1 MYO16 PLCE1 | 1.27e-03 | 1345 | 267 | 24 | EFO_0010736 |
| Disease | IGFBP-3 measurement | 1.45e-03 | 54 | 267 | 4 | EFO_0004626 | |
| Disease | lysophosphatidylethanolamine 16:0 measurement | 1.63e-03 | 26 | 267 | 3 | EFO_0010366 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 1.66e-03 | 7 | 267 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | GLS2 MYO5A PALMD ADHFE1 FAT1 ALDH1L2 L3HYPDH COL6A1 NOX4 NBEA RMDN2 ATP10D GSTA2 MYO1F PPP1R18 CDK1 | 1.98e-03 | 774 | 267 | 16 | C0023893 |
| Disease | hyperthyroidism (biomarker_via_orthology) | 2.03e-03 | 28 | 267 | 3 | DOID:7998 (biomarker_via_orthology) | |
| Disease | cortex volume change measurement, age at assessment | 2.03e-03 | 28 | 267 | 3 | EFO_0008007, EFO_0021500 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 2.04e-03 | 307 | 267 | 9 | EFO_0004612, EFO_0020946 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.07e-03 | 195 | 267 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | vital capacity | CWC27 RPS6KA1 DNAJC27 WARS2 BOK ADAMTS18 DLG1 MYO18B MTCH2 PAPPA2 LAMA2 APOB CPE ZNF106 CAPRIN2 MYO1F NR5A2 LTBP3 EIF3H TNS1 MYO16 PLCE1 | 2.08e-03 | 1236 | 267 | 22 | EFO_0004312 |
| Disease | Muscular Dystrophy | 2.20e-03 | 8 | 267 | 2 | C0026850 | |
| Disease | butyrylcarnitine (C4) measurement | 2.20e-03 | 8 | 267 | 2 | EFO_0800201 | |
| Disease | disease recurrence, malaria | 2.20e-03 | 8 | 267 | 2 | EFO_0001068, EFO_0004952 | |
| Disease | butyrylcarnitine measurement | 2.20e-03 | 8 | 267 | 2 | EFO_0020010 | |
| Disease | Ataxias, Hereditary | 2.20e-03 | 8 | 267 | 2 | C0004138 | |
| Disease | isobutyrylcarnitine measurement | 2.20e-03 | 8 | 267 | 2 | EFO_0021023 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 2.25e-03 | 29 | 267 | 3 | cv:C5779548 | |
| Disease | Liver carcinoma | ACACA GAPDH ETFA UROC1 MELK ACSL4 HSPA5 STAB2 NCAPH SCAP CDK1 EIF3H | 2.41e-03 | 507 | 267 | 12 | C2239176 |
| Disease | Parkinsonian Disorders | 2.48e-03 | 30 | 267 | 3 | C0242422 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.77e-03 | 153 | 267 | 6 | EFO_0004611, EFO_0020946 | |
| Disease | obsolete_red blood cell distribution width | CFAP251 MYO1D NT5C3A AS3MT CDH23 BIRC6 DKC1 AFDN ATP11C OSBP2 PMS2P1 ABCC1 DNAJC13 POLR1A BAZ2B HIP1R CENPO SHMT1 APOB RHD GSTA2 PDLIM4 MYO16 | 2.79e-03 | 1347 | 267 | 23 | EFO_0005192 |
| Disease | corticobasal degeneration disorder | 2.82e-03 | 9 | 267 | 2 | MONDO_0022308 | |
| Disease | post-traumatic stress disorder (biomarker_via_orthology) | 2.82e-03 | 9 | 267 | 2 | DOID:2055 (biomarker_via_orthology) | |
| Disease | interleukin 1 receptor-like 2 measurement | 2.82e-03 | 9 | 267 | 2 | EFO_0008169 | |
| Disease | glycosyl-N-stearoyl-sphingosine (d18:1/18:0) measurement | 2.82e-03 | 9 | 267 | 2 | EFO_0800275 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 2.88e-03 | 65 | 267 | 4 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | total lipids in very large HDL measurement | 3.04e-03 | 66 | 267 | 4 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 3.04e-03 | 66 | 267 | 4 | EFO_0022298 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 3.21e-03 | 67 | 267 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 3.27e-03 | 33 | 267 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | retinal degeneration (implicated_via_orthology) | 3.27e-03 | 33 | 267 | 3 | DOID:8466 (implicated_via_orthology) | |
| Disease | Calcium channel blocker use measurement | 3.39e-03 | 213 | 267 | 7 | EFO_0009930 | |
| Disease | long QT syndrome (implicated_via_orthology) | 3.50e-03 | 10 | 267 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | cholesterol in very large HDL measurement | 3.57e-03 | 69 | 267 | 4 | EFO_0022229 | |
| Disease | facial morphology measurement | CFAP251 WARS2 MYO18B DNMT3B FAT4 GTF2A1L POLR1A ZNF106 SORCS3 EIF3H MYO16 | 3.69e-03 | 466 | 267 | 11 | EFO_0007841 |
| Disease | amino acid measurement | SETX GLS2 ACACB ABCA12 NEK4 NDST3 PTPRB SHPRH FAT4 GTF2A1L UNC13C GRIP2 CTSV MYO16 | 3.75e-03 | 678 | 267 | 14 | EFO_0005134 |
| Disease | lymphocyte count | TNIK ACACA MYO1D RPS6KA1 CDH23 UROC1 NHLRC2 LYST STK11 DNMT3B ABCC1 ADAP1 ZAN PCDHGB7 PCDHGB6 PCDHGB2 PCDHGB1 PCDHGA6 SBNO2 PDLIM4 CD28 LSP1 LTBP3 PLCE1 | 3.79e-03 | 1464 | 267 | 24 | EFO_0004587 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.82e-03 | 276 | 267 | 8 | EFO_0004612, EFO_0020943 | |
| Disease | retinal detachment, retinal break | 3.87e-03 | 35 | 267 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 3.87e-03 | 35 | 267 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | Colorectal Neoplasms | 3.91e-03 | 277 | 267 | 8 | C0009404 | |
| Disease | uric acid measurement | TNIK BIRC6 F5 KIAA0319 ANKRD52 FAT4 DNAJC13 POLR1A SLC16A9 FAT3 CEMIP MYOF NR5A2 | 3.96e-03 | 610 | 267 | 13 | EFO_0004761 |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 4.20e-03 | 36 | 267 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | response to serotonin-norephinephrine reuptake inhibitor | 4.20e-03 | 36 | 267 | 3 | EFO_0006325 | |
| Disease | response to ondansetron, QT interval | 4.25e-03 | 11 | 267 | 2 | EFO_0004682, EFO_0020997 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 4.25e-03 | 11 | 267 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | guanosine diphosphate measurement | 4.25e-03 | 11 | 267 | 2 | EFO_0010494 | |
| Disease | beta thalassemia (is_marker_for) | 4.25e-03 | 11 | 267 | 2 | DOID:12241 (is_marker_for) | |
| Disease | Pancreatic Ductal Adenocarcinoma | 4.25e-03 | 11 | 267 | 2 | C1335302 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 4.50e-03 | 169 | 267 | 6 | DOID:3908 (is_marker_for) | |
| Disease | high density lipoprotein particle size measurement | 4.63e-03 | 170 | 267 | 6 | EFO_0008592 | |
| Disease | intellectual disability (implicated_via_orthology) | 4.82e-03 | 75 | 267 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Nonsyndromic genetic hearing loss | 5.05e-03 | 76 | 267 | 4 | cv:C5680182 | |
| Disease | diabetic angiopathy (is_marker_for) | 5.07e-03 | 12 | 267 | 2 | DOID:11713 (is_marker_for) | |
| Disease | Congenital muscular dystrophy | 5.07e-03 | 12 | 267 | 2 | cv:C0699743 | |
| Disease | mean platelet volume | CFAP251 MYH11 GLS2 MYO5A NUP210L TUBA8 ACSL4 RASSF5 PIK3CB KLHL8 ZAN PCDHGB7 PCDHGB6 PCDHGB2 PCDHGB1 PCDHGA6 HIP1R PLCE1 | 5.65e-03 | 1020 | 267 | 18 | EFO_0004584 |
| Disease | homostachydrine measurement | 5.96e-03 | 13 | 267 | 2 | EFO_0021164 | |
| Disease | opioid dependence | 6.03e-03 | 237 | 267 | 7 | EFO_0005611 | |
| Disease | tea consumption measurement | 6.48e-03 | 129 | 267 | 5 | EFO_0010091 | |
| Disease | age at menopause | 6.50e-03 | 302 | 267 | 8 | EFO_0004704 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 6.62e-03 | 303 | 267 | 8 | EFO_0004612, EFO_0020945 | |
| Disease | thalamus volume change measurement | 6.91e-03 | 14 | 267 | 2 | EFO_0021496 | |
| Disease | Spastic Paraplegia, Hereditary | 6.91e-03 | 14 | 267 | 2 | C0037773 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 6.91e-03 | 14 | 267 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 6.91e-03 | 14 | 267 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 6.92e-03 | 43 | 267 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | Alzheimer's disease (is_implicated_in) | 7.12e-03 | 132 | 267 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | Adverse reaction to drug | 7.18e-03 | 84 | 267 | 4 | C0041755 | |
| Disease | carotid plaque build | 7.18e-03 | 84 | 267 | 4 | EFO_0006501 | |
| Disease | Drug toxicity | 7.18e-03 | 84 | 267 | 4 | C0013221 | |
| Disease | Global developmental delay | 7.35e-03 | 133 | 267 | 5 | C0557874 | |
| Disease | diet measurement | NUP210L KCTD8 KDM3B CAPN8 RGMA NALCN CHD6 DNMT3B SLC4A8 ZNF618 LAMA2 NOX3 APOB LARS2 SORCS3 DGKI UNC13C MYO16 | 7.45e-03 | 1049 | 267 | 18 | EFO_0008111 |
| Disease | liver fibrosis measurement | 7.79e-03 | 86 | 267 | 4 | EFO_0010576 | |
| Disease | severe acute respiratory syndrome, COVID-19 | CWC27 LYST WARS2 RASSF5 SORCS2 ATP8B3 LSP1 UNC13C LTBP3 FGGY | 7.92e-03 | 447 | 267 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | head and neck squamous cell carcinoma (is_implicated_in) | 7.92e-03 | 15 | 267 | 2 | DOID:5520 (is_implicated_in) | |
| Disease | anemia (implicated_via_orthology) | 7.92e-03 | 15 | 267 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | 1,3,7-trimethylurate measurement | 7.92e-03 | 15 | 267 | 2 | EFO_0021172 | |
| Disease | Hypertriglyceridemia | 7.92e-03 | 15 | 267 | 2 | C0020557 | |
| Disease | Myopia | 7.92e-03 | 15 | 267 | 2 | C0027092 | |
| Disease | inflammatory bowel disease | 8.16e-03 | 449 | 267 | 10 | EFO_0003767 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DGVANVEHILKIGYL | 286 | Q9H0P0 | |
| DGLGFLYVTGHIKEI | 501 | Q5FVE4 | |
| LYVTGHIKEILITAG | 506 | Q5FVE4 | |
| TLEVAKQGAIYHGLA | 1086 | P55196 | |
| YATLGKEAVVHGLNE | 181 | O60488 | |
| TAGYQGLLAIVKAAV | 96 | Q5U5X8 | |
| IGVQAVHYNGVLAAK | 511 | P16452 | |
| GHVKEIYKLVALGTG | 251 | Q8NCV1 | |
| VLKIIKHYQEEGQGT | 46 | O15372 | |
| GHLVITTQGGYVKIL | 901 | Q9NR09 | |
| YSVIIKTLLHAGGFQ | 211 | O00574 | |
| KHTIFGKVTGDTVYN | 126 | Q6UX04 | |
| HKGLDSAVEVCVVYG | 56 | P10747 | |
| IAVGTVKHEGNIKYV | 611 | Q9UBC3 | |
| GTSKSGVQYKGHVEI | 91 | O95433 | |
| SSKNLDHGVLVVGYG | 271 | O60911 | |
| DLTVGVALHGVTKIY | 1341 | Q86UK0 | |
| VALHGVTKIYGSKVA | 1346 | Q86UK0 | |
| GLITGYKAKTALGEH | 1151 | Q9UIF8 | |
| DSGAVYTLALKTHIG | 531 | Q3SY69 | |
| NSIYVTKIIEGGAAH | 346 | Q12959 | |
| IGTVGLTEDEAIHKY | 421 | P00390 | |
| KGSEHVAYGAITLEL | 311 | Q14832 | |
| GNHFTIDEVKGTIYT | 1466 | Q6V0I7 | |
| AIHDKDYVKAGGILQ | 66 | Q9UDR5 | |
| GATEADYHLHKVGIV | 121 | Q8NCL9 | |
| KGVYVRVGLQKISHS | 776 | P52824 | |
| GVTLVSVTKEYEGHK | 3841 | Q86UQ4 | |
| VAVLDQGKITEYGKH | 701 | Q9NRK6 | |
| QGKITEYGKHEELLS | 706 | Q9NRK6 | |
| KLIQYIVEDGGHVFA | 761 | Q13085 | |
| EVFIGSKESGYTVLH | 296 | O75689 | |
| HGQVVSYLLKSGADK | 56 | Q6AI12 | |
| VKKYHQVVTLAIGDG | 926 | O60423 | |
| QKLVKSHAYSVTGVE | 256 | A6NHC0 | |
| LIEAAKGGHTSVVCY | 701 | O75179 | |
| HTAAASGQIEVVKYL | 211 | Q8NB46 | |
| KDTIINAKYGGHTEA | 426 | Q7L5Y6 | |
| GKVVSLYAVAAGLAV | 121 | Q9UMX3 | |
| YSHGFILTVKGTELN | 306 | Q9H251 | |
| TVYSIHISEGGKLVI | 71 | Q8WUJ3 | |
| YHNTGITGITEAVKE | 111 | Q9NT62 | |
| VGIVIYAGHETKALL | 276 | O60312 | |
| AVVGIVVYAGHETKA | 286 | Q9P241 | |
| VEKHGKGNVTTYILT | 306 | Q8TE60 | |
| YKAGSLLVIGHLVVN | 341 | Q9BV10 | |
| TGDIKGNIKFYDHTL | 516 | Q8TBY9 | |
| GVLGTVVHGKVLQHY | 81 | Q9Y6C9 | |
| EYGVGVIGFHKTSEK | 156 | O95803 | |
| SEDGTYTGFIKVHLK | 231 | Q8WWW0 | |
| AIGVGKTSLLHQYVH | 16 | Q96AH8 | |
| TKLGIDHYVASVNVV | 401 | Q6ZRI8 | |
| FEKVLKSHGQDYLVG | 136 | P08263 | |
| EYKLSHGSVVIAAVI | 496 | P48200 | |
| VHGDVVKYGSVIQLL | 111 | Q14573 | |
| YLVTKVVAVDADSGH | 586 | Q9Y5F9 | |
| YLVTKVVAVDADSGH | 586 | Q9Y5F8 | |
| YELHETIGTGGFAKV | 11 | Q14680 | |
| HLYLGAAKVKEGVEV | 1521 | O00763 | |
| LLVGVIDELHYTAKG | 176 | Q9H790 | |
| GGVIGKIHATDQDVY | 3561 | Q14517 | |
| KTVGIEKLAHAYGIL | 421 | Q7RTY1 | |
| KFLTGYDGIIHAELV | 431 | Q9NP74 | |
| RVIGTKGDIAHIYDI | 1191 | Q9Y4B6 | |
| TVGDLEGCVHYKVVK | 1016 | O95819 | |
| ILVHGGVVDKHATSY | 241 | P23467 | |
| EGVHGEVTYSFVKIT | 271 | Q9Y5G7 | |
| VELNVGGQVYVTKHS | 46 | Q6ZWB6 | |
| YISAGEHVKAIEICG | 771 | Q9HBG6 | |
| AADYKILGGSVLHLV | 56 | Q15843 | |
| AVEKPLSVGHKVAGY | 336 | Q8N468 | |
| DTLGIYGKVNIHSIG | 136 | O00214 | |
| ASGYKEVVSLILEHG | 231 | Q9Y6X6 | |
| LATIGIDYGVTKVHV | 46 | Q9NZQ0 | |
| VYAAGKAEVILGSII | 141 | Q14722 | |
| QVVTRVDKGGALHIY | 451 | Q07954 | |
| GFYVSKALVHTGVAL | 296 | Q76MJ5 | |
| VHLVGIDIFTGKKYE | 56 | Q9GZV4 | |
| HQKGKDEGVVYSVVH | 361 | Q6DN72 | |
| FEKVLKSHGQDYLVG | 136 | P09210 | |
| ILEQIVSVGKHVKGY | 221 | P48058 | |
| IAEAYLGGKVHSAVI | 131 | P54652 | |
| DGITKLNTIGHYEIS | 1281 | O60486 | |
| DKGKSLIYTIHGSQD | 1476 | Q9NYQ8 | |
| SEYIHAQVASGKGKL | 86 | Q75LS8 | |
| VISVEGKVYAVGGHD | 361 | Q9P2G9 | |
| LGSVVYAHSKELVTA | 221 | O43526 | |
| VESLSLQGSYAGKIH | 26 | Q1X8D7 | |
| YVLSVEAKDGGVHTA | 311 | Q9Y5G3 | |
| YLVTKVVAVDADSGH | 586 | Q9Y5G2 | |
| AAEGLISYAIQKGHL | 136 | Q96LB9 | |
| HVTYAGAAVDELGKV | 26 | P30086 | |
| VVGKGSYGEVTLVKH | 11 | P51957 | |
| KIFQEYGTVGVSLHI | 91 | Q96KR6 | |
| STGKVVVYDLLSGHI | 461 | Q8TEB1 | |
| LQGLSSIHVYGKTED | 1006 | Q96J66 | |
| GIYVSKVTVGSIAHQ | 1371 | Q8TDM6 | |
| KVTVGSIAHQAGLEY | 1376 | Q8TDM6 | |
| VKNIIYHAVKDAVGT | 1736 | Q7LBC6 | |
| AGGVYETTQHFIDIK | 426 | P49257 | |
| VHLVGIDIFTGKKYE | 56 | P63241 | |
| STLGTDYVHKFVGKE | 231 | Q9UI32 | |
| VELTDGHIKVSYDLG | 2391 | P24043 | |
| EIVSALEYLHGKGII | 161 | Q6A1A2 | |
| VGTRLVFDHYGKIIQ | 331 | A4D2B8 | |
| TTGQVKAVTSGHYVL | 1071 | Q9NQV6 | |
| VTGVVSDSQGKAHYV | 731 | Q969R2 | |
| TVTVGGKQHLLGLYD | 61 | Q9H4E5 | |
| TYEHGVKLAKAIGAQ | 156 | Q9H4E5 | |
| TYSDKDGLLIIGVHS | 106 | Q8NBF2 | |
| TDGIQKIIGEKYHAL | 501 | Q9NPH5 | |
| QLIGIGKHSAAAELY | 1341 | Q9UG01 | |
| VGGLKESAVHSQYKR | 641 | Q99575 | |
| GGISQILDLVKGTHY | 406 | P49643 | |
| YGIRIDVIVHGQAGK | 321 | Q9UBL9 | |
| HSGKQYEVLNGITVS | 201 | Q9HB29 | |
| LHVDGKVSGVKVYTF | 1011 | Q9BXP8 | |
| HEVLTEYKEGVGKFI | 71 | Q9H974 | |
| ISIVTKEKGVVFAHY | 156 | Q7Z449 | |
| VLAKTEGLGNYSIHL | 1046 | Q8N0W3 | |
| TGVRDYIHVVDLAKG | 236 | Q14376 | |
| YELNVLGTHKIEDGT | 3926 | P04114 | |
| AALVYVENAHVAGKT | 71 | Q14008 | |
| LVEAADKVVLHTGKY | 886 | O75146 | |
| EYILGTVHKAKGLEF | 866 | Q8NFZ0 | |
| LGVYNLEIVDKQGHT | 106 | Q9BYI3 | |
| GKYILHDNGTLVIKE | 2481 | Q6WRI0 | |
| VHLVGIDIFTGKKYE | 56 | Q6IS14 | |
| LVGGSHLKENKYLIV | 141 | P12109 | |
| ADKSLLIGVFKHGYE | 1281 | Q8TD26 | |
| SLLHYAAKTGNGEIV | 961 | O75912 | |
| INETKHSVLQYVGGV | 126 | Q96C11 | |
| GHSYVGKEELIGIAV | 4146 | Q8TDW7 | |
| ISYLEQIHRGVKGFV | 366 | P16870 | |
| EGIKVQTKEGGYFHV | 1236 | O75976 | |
| GYINVASLKETHGIQ | 761 | Q5VVM6 | |
| GNIYHILGKVKFSDS | 1006 | Q5TEA3 | |
| YVLSQLVGEKGHVTG | 86 | Q9HBK9 | |
| ASNVTFIHGYIEKLG | 126 | Q9HBK9 | |
| YIVAFAAKVLTGQVH | 301 | P27544 | |
| LEGSEKAVVGTTYKH | 286 | Q6IMN6 | |
| IKSAIDHAGNYIGIS | 191 | O75165 | |
| TEYKTIQGILHEIGG | 1796 | Q99698 | |
| GDSVASKHAIYAVQV | 176 | Q9NS15 | |
| KTYGHSSVEELLGAI | 1526 | Q9Y4F3 | |
| GLIVHEGAAVYRVFK | 296 | A6NNE9 | |
| VATGHGKYEKVLVEG | 321 | P33241 | |
| VKAILQAYHFTGLSG | 101 | Q9BU64 | |
| QHGDTFTVLLGGKYI | 76 | O75881 | |
| HALVVCGTYSIGKEK | 871 | Q6PJP8 | |
| TLVTGKYIENHGVVH | 81 | Q6UWV6 | |
| SVSDGLLEKGVYVHT | 956 | Q9C0E4 | |
| TAEAYLGKKVTHAVV | 156 | P11021 | |
| IKGHAYSVTGIDQVS | 251 | O14815 | |
| QKLVKGHAYSVTGAE | 256 | P17655 | |
| QQSAGKEYVGIVRLH | 146 | O60832 | |
| IDVTVGVKIHRGYKT | 276 | P51530 | |
| GESAYQKLGLTEAHK | 226 | Q6NYC8 | |
| QAHGDVTLYKVAALG | 701 | Q12770 | |
| VVEYLSTGGVETNHK | 421 | Q9ULM6 | |
| KHGLVYSSAELKVVA | 391 | Q9P232 | |
| LVLKVFGYRSVQGDH | 106 | Q9UNU6 | |
| NGSYHIVKALKDGVV | 416 | Q5VU65 | |
| KGFSLTVLEAGTYHV | 1681 | P98161 | |
| VNTSVRHGGIYVKAV | 1386 | Q12923 | |
| KFDEIYGTLHITGQV | 331 | Q8WV60 | |
| HQGYLAIDEVKVLGH | 166 | P28827 | |
| GTTNVYRVGHKGKVD | 206 | Q96AX9 | |
| GVAIFDYEHLKVKIG | 196 | Q8IWW8 | |
| DKVEGHVAIKGSVAY | 696 | P33527 | |
| GYKIVTGGSDNHLIL | 346 | P34896 | |
| IYRQVVHGKEGSIFL | 391 | O00482 | |
| FVTVGAHKTGVVRYV | 1706 | Q9NQT8 | |
| GVLYVGSKTKEGVVH | 36 | P37840 | |
| YGNVKVSGEILLHIS | 401 | Q8TDW5 | |
| KTKGIEVGHTFYLGT | 301 | Q7L3T8 | |
| TTKQKHDGTVGLLTY | 146 | Q9UGM6 | |
| VKADGHKVYGAILVA | 351 | Q9Y6J9 | |
| VKASHILISVDGKVY | 196 | Q7RTN6 | |
| DYIIGDTGITKGKHF | 561 | Q9NQ86 | |
| SLAHGAVIYATKGIT | 1546 | O95602 | |
| NESVGLGYLKTHAIE | 596 | Q15147 | |
| IYIVSTVFCGHLGKV | 51 | Q86VL8 | |
| KVHGQATGEKLTAYT | 286 | Q15031 | |
| ASLVFGNYLVHIGAK | 86 | Q6NT16 | |
| VIITGIQTQGAKHYL | 1971 | P12259 | |
| GKDSIQYGRVKATVH | 921 | O95255 | |
| LTNGHIYVSGDQKEI | 286 | Q8NFW8 | |
| LTGHQLKGESSVELY | 1411 | Q9P212 | |
| EDGIKHVYKSAGIFQ | 876 | Q9UPU3 | |
| KIVAYELKTGGVLLH | 401 | Q6P1X5 | |
| TAEIVSALEYLHGKG | 186 | O15530 | |
| AGIAKVLVAQHDVYK | 71 | P13804 | |
| KGILGYTEHQVVSSD | 271 | P04406 | |
| KIDTKVLAYTEGLHG | 2191 | Q8NFP9 | |
| GIVGTIVKARDKLYH | 261 | P50479 | |
| YQGTIVLATVKGDVH | 771 | Q99707 | |
| GYINASHIKVVVGGA | 961 | Q15678 | |
| IGQTSSVGIHYLVAK | 821 | Q9NZC9 | |
| YLDHGGVIVAIKDTS | 566 | Q96PQ0 | |
| KIHLAYERGASGAVI | 131 | Q8TEB7 | |
| ISTVAGGKYGVAHVV | 16 | Q8IUH8 | |
| YLGKTVQVVPHITDA | 106 | P17812 | |
| YVAQLRDHGKTVGVV | 1306 | Q7Z333 | |
| AGIHIIKGEYALAAE | 1031 | Q149N8 | |
| YIQDELGGKITVHKI | 106 | Q96LZ7 | |
| TGIAVHALSKIKYGD | 326 | Q9Y2G9 | |
| LLLVVGYSHSKGVAI | 391 | Q9P2U7 | |
| VTAYLLEKKGDIHGA | 1071 | Q8N3P4 | |
| HGHVEVVKLLVGAYD | 351 | Q53LP3 | |
| IDGLEYLHSQGIVHK | 161 | Q15831 | |
| QGGTSTILNIHYEKE | 26 | Q2Y0W8 | |
| TGVVLYHLKEGTTKI | 491 | Q9P2P6 | |
| YHLKEGTTKIGRIDS | 496 | Q9P2P6 | |
| KLYGGKLIVAVHFEN | 191 | P42338 | |
| FLVGRVAHTVAYLGK | 106 | O14684 | |
| YTEVGEITTDLGKHQ | 741 | Q9Y5B9 | |
| FHKLVAYGIAVNATI | 101 | Q9HBY0 | |
| SGQHVEIQAKYIGTT | 266 | Q96B86 | |
| KAVIVEVSGQAHYTG | 321 | Q96EM0 | |
| VVLGTGYKLVQAGHF | 2951 | Q9NRC6 | |
| GVLKEGHTYATVVKL | 2086 | Q6Q759 | |
| GHTYATVVKLKNVGV | 2091 | Q6Q759 | |
| VKLTVVRGKYDCGHV | 121 | O15235 | |
| IEIVVYTGKEGKSSH | 1466 | Q8NFU7 | |
| IYVHGDSLKAFLVGI | 586 | Q9UKU0 | |
| GVVYKGRHKTTGQVV | 16 | P06493 | |
| AAVGAYVKVHTVEQG | 406 | Q96M20 | |
| YVKVHTVEQGEILGL | 411 | Q96M20 | |
| AVHADVYRVLGGLGK | 171 | Q15003 | |
| TKGFHTTIDIGVKYA | 131 | Q15417 | |
| SKKGIVQSIVGQGYH | 416 | Q9H9A5 | |
| GHKYKGVTQEVDGLS | 431 | Q8NB49 | |
| VIQYLAVVASSHKGK | 191 | P35749 | |
| IERGHKVIIVTHAYG | 61 | P37287 | |
| KVIIVTHAYGNRKGI | 66 | P37287 | |
| ASVYSDIVGKIVGKH | 71 | Q9ULP9 | |
| QRAIVGHVDLYKGTV | 266 | O95258 | |
| YLGKTVQVVPHITDA | 106 | Q9NRF8 | |
| ITVGDLEGCIHYKVV | 1136 | Q9UKE5 | |
| AEGNHIKSYVLGVKG | 571 | Q5T7W0 | |
| SKTYVHSAVLAGGVA | 266 | Q02161 | |
| FHYLTEVKSNGGVKI | 1371 | Q8NB66 | |
| GINYEIVVAHVSKFS | 546 | O75970 | |
| AEAIVYKHGSGRIKV | 281 | P82933 | |
| AGVTLQTVSGHLYKV | 121 | Q9UNN4 | |
| KKEVLSLGYHGNVVA | 306 | Q96N76 | |
| GQDLIITGSKDHYIK | 1506 | Q7Z4S6 | |
| SKIQNVGGTYELHVG | 131 | Q9UNG2 | |
| AGVYQVSGLHNKVAT | 1251 | Q9HBL0 | |
| GYILDPHTAVAKVVA | 636 | Q8IYQ7 | |
| INYTNVATDKGVIHG | 1246 | Q8WWQ8 | |
| VLQGTSVASVYHGKI | 326 | Q15166 | |
| SVASVYHGKILIGTV | 331 | Q15166 | |
| VAVGHSQVFLKAGVI | 1311 | Q8IUG5 | |
| QFGHTSIVAYLIAKG | 166 | Q8IUH5 | |
| IETGKCLVKYAGHVG | 186 | Q9Y2I8 | |
| CLVKYAGHVGSVNSI | 191 | Q9Y2I8 | |
| GILVGKHVDAQGRIY | 96 | Q8IX04 | |
| EGAILTLAGKYSAVH | 191 | Q969M1 | |
| GSSNLTIYKKIHAGE | 246 | Q9NSJ1 | |
| HKAAITTLKYDQLGG | 106 | Q9UNX4 | |
| AATHVVTSQVKYLLG | 186 | Q8TE54 | |
| AVIGHYTLKIEISQG | 111 | Q96PF1 | |
| YTLKIEISQGQGHSV | 116 | Q96PF1 | |
| GVTEVGLSAYAKHIS | 26 | Q9H2Y7 | |
| GHYTVGKESIDLVLD | 106 | Q9NY65 | |
| LGVTLHKVVVAGALY | 326 | Q8NBN3 | |
| HKVVVAGALYLLFSG | 331 | Q8NBN3 | |
| VFGTVKEDVSLHGYK | 121 | Q12792 | |
| DTHKIAVLYVGEGQS | 1541 | P49815 | |
| KAQTEVGKHYLQLAG | 101 | O76024 | |
| GGILEVSYIKAVHVT | 1591 | Q9Y493 | |
| KAIATVTGLQVGTYH | 676 | Q5VV43 | |
| LHTIGKTVEYLHSQG | 516 | Q15418 | |
| HIVNTYGAFGSITKE | 401 | Q96S06 | |
| HIRGIVKGDSSYVKD | 91 | Q8IZF0 | |
| KNYDTTIHGKNTVIG | 366 | O94832 | |
| TIHGKNTVIGVLDIY | 371 | O94832 | |
| YISKVSGGGEKVQHV | 126 | O00160 | |
| AVKQHSFIGVLDIYG | 426 | Q9Y4I1 | |
| QGLYCDVSVVVKGHA | 26 | Q96RE7 | |
| EKSSVVGGFVSHYLL | 216 | Q9UM54 | |
| NDVVGTTYLHLSKIA | 451 | Q9NZM1 | |
| LGTTAVKVAAHKLYE | 246 | Q8N9F0 | |
| GTYTVQIHDGKAKSQ | 1086 | P54296 | |
| GEKIDVTVSVYKHGE | 1426 | P54296 | |
| AGGEGKHITVFKTYI | 171 | Q9NP98 | |
| VYTVELHIGKVVLGD | 116 | Q14324 |